UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August, 2018

 

Commission File Number: 000-55135

 

POET TECHNOLOGIES INC.
(Translation of registrant’s name into English)

 

120 Eglinton Avenue East, Ste. 1107
Toronto, Ontario M4P 1E2, Canada
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

 

 

 

 

INCORPORATION BY REFERENCE

 

This report on Form 6-K, including the unaudited consolidated financial statements for the three and six months ended June 30, 2018 and management’s discussion and analysis for the three and six months ended June 30, 2018, shall be deemed to be incorporated by reference as exhibits to the Registration Statement of POET Technologies Inc. on Form F-10 (File No. 333-213422) and to be a part thereof from the date on which this report was furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

EXHIBIT LIST

 

Exhibit No. Description

 

99.1 Unaudited consolidated Financial Statements for the Three and Six Months Ended June 30, 2018

 

99.2 Management’s Discussion and Analysis for the Three and Six Months Ended June 30, 2018

 

99.3 Certification of Interim Filings by Chief Executive Officer, dated August 15, 2018

 

99.4 Certification of Interim Filings by Chief Financial Officer, dated August 15, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Dated: August 15, 2018

 

 

    POET TECHNOLOGIES INC.
     
     
     
    By: /s/ John F. O’Donnell                    
    Name: John F. O’Donnell
    Title: Director and Corporate Secretary

 

 

 

 

 

Exhibit 99.1

 

 

 

 

 

 

 

 

 

 

 

NOTICE TO SHAREHOLDERS

For the Six Months Ended June 30, 2018

(Unaudited and Expressed in US Dollars)

 

POET TECHNOLOGIES INC.

 

 

 

 

 

 

 

 

Page 1

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION         Audited  
(Expressed in US Dollars)   June 30,     December 31,  
    2018     2017  
             
Assets                
Current                
Cash   $ 9,991,005     $ 4,974,478  
Accounts receivable (Note 4)     433,608       493,925  
Prepaids and other current assets (Note 5)     1,651,911       1,957,727  
Inventory (Note 6)     424,513       524,582  
                 
      12,501,037       7,950,712  
Property and equipment (Note 7)     9,140,245       8,278,170  
Patents and licenses (Note 8)     441,120       456,250  
Intangible assets (Note 9)     821,023       839,637  
Goodwill (Note 2)     7,681,003       7,681,003  
                 
    $ 30,584,428     $ 25,205,772  
                 
Liabilities                
                 
Current                
Accounts payable and accrued liabilities (Note 10)   $ 1,909,141     $ 810,593  
                 
      1,909,141       810,593  
                 
Deferred tax liability     1,149,397       1,298,367  
Deferred rent     12,347       24,031  
                 
      3,070,885       2,132,991  
                 
                 
Shareholders' Equity                
                 
Share capital (Note 11(b))     111,956,196       103,616,221  
Warrants and compensation options (Note 12)     8,303,738       5,985,378  
Contributed surplus (Note 13)     33,881,677       32,102,967  
Accumulated other comprehensive loss     (1,967,101 )     (1,758,632 )
Deficit     (124,660,967 )     (116,873,153 )
                 
      27,513,543       23,072,781  
                 
    $ 30,584,428     $ 25,205,772  

 

Commitments and contingencies (Note 15)

 

On behalf of the Board of Directors

 

 

/s/ Suresh Venkatesan   /s/ Chris Tsiofas
Director   Director

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

Page 2

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND DEFICIT

(Expressed in US Dollars)

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Revenue (Note 21)   $ 752,198     $ 648,382     $ 1,425,427     $ 1,360,932  
                                 
Cost of sales     319,939       320,857       588,117       609,048  
                                 
Gross margin     432,259       327,525       837,310       751,884  
                                 
                                 
Operating expenses                                
Selling, marketing and administration (Note 20)     2,917,957       2,127,083       5,583,493       4,923,477  
Research and development (Note 20)     2,046,576       1,244,258       3,796,492       2,482,678  
Other (loss) income, including interest     155,218       (142,557 )     (605,891 )     (162,364 )
                                 
Operating expenses     5,119,751       3,228,784       8,774,094       7,243,791  
                                 
Net loss before income tax recovery     (4,687,492 )     (2,901,259 )     (7,936,784 )     (6,491,907 )
Income tax recovery     (74,485 )     (74,485 )     (148,970 )     (148,970 )
                                 
Net loss     (4,613,007 )     (2,826,774 )     (7,787,814 )     (6,342,937 )
                                 
                                 
Deficit, beginning of period     (120,047,960 )     (107,591,519 )     (116,873,153 )     (104,075,356 )
Net loss     (4,613,007 )     (2,826,774 )     (7,787,814 )     (6,342,937 )
                                 
Deficit, end of period   $ (124,660,967 )   $ (110,418,293 )   $ (124,660,967 )   $ (110,418,293 )
                                 
Basic and diluted net loss per share (Note 14)   $ (0.02 )   $ (0.01 )   $ (0.03 )   $ (0.02 )

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Expressed in US Dollars)

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
                         
Net loss   $ (4,613,007 )   $ (2,826,774 )   $ (7,787,814 )   $ (6,342,937 )
                                 
Other comprehensive income - net of income taxes                                
Exchange differences on translating foreign operations     (469,441 )     194,694       (208,469 )     313,792  
                                 
Comprehensive loss   $ (5,082,448 )   $ (2,632,080 )   $ (7,996,283 )   $ (6,029,145 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

Page 3

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(Expressed in US Dollars)

 

For the Six Months Ended June 30,   2018     2017  
Share Capital            
Beginning balance   $ 103,616,221     $ 103,357,862  
Funds from the exercise of warrants     1,028,471       -  
Fair value assigned to warrants exercised     447,270       -  
Funds from the exercise of stock options     82,275       102,045  
Fair value assigned to stock options exercised     77,185       112,829  
Funds from common shares issued on public offering     10,663,548       -  
Share issue costs     (1,193,144 )     -  
Fair value of compensation options issued to brokers     (479,204 )     -  
Fair value of warrants issued on public offering     (2,286,426 )     -  
                 
June 30,     111,956,196       103,572,736  
                 
Warrants                
Beginning balance     5,985,378       5,985,378  
Fair value of warrants issued on public offering     2,286,426       -  
Fair value of compensation options issued to brokers     479,204       -  
Fair value assigned to warrants exercised     (447,270 )     -  
                 
June 30,     8,303,738       5,985,378  
                 
Contributed Surplus                
Beginning balance     32,102,967       29,062,874  
Stock-based compensation     1,855,895       1,054,596  
Fair value of stock options exercised     (77,185 )     (112,829 )
                 
June 30,     33,881,677       30,004,641  
                 
Accumulated Other Comprehensive Loss                
Beginning balance     (1,758,632 )     (2,088,117 )
Other comprehensive income attributable to common shareholders - translation adjustment     (208,469 )     313,792  
                 
June 30,     (1,967,101 )     (1,774,325 )
                 
Deficit                
Beginning balance     (116,873,153 )     (104,075,356 )
Net loss     (7,787,814 )     (6,342,937 )
                 
June 30,     (124,660,967 )     (110,418,293 )
                 
Total shareholders' equity   $ 27,513,543     $ 27,370,137  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

Page 4

 

POET TECHNOLOGIES INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in US Dollars)

 

For the Six Months Ended June 30,   2018     2017  
             
CASH (USED IN) PROVIDED BY:                
                 
OPERATING ACTIVITIES                
                 
Net loss   $ (7,787,814 )   $ (6,342,937 )
Adjustments for:                
Depreciation of property and equipment (Note 7)     1,208,425       1,054,497  
Amortization of patents and licenses (Note 8)     28,796       26,201  
Amortization of intangibles (Note 9)     18,614       18,614  
Deferred rent     (11,260 )     -  
Stock-based compensation (Notes 13 and 20)     1,855,895       1,054,596  
Income tax recovery     (148,970 )     (148,970 )
                 
      (4,836,314 )     (4,337,999 )
Net change in non-cash working capital accounts:                
Accounts receivable and unbilled revenue     52,453       (217,879 )
Prepaid and other current assets     8,894       149,145  
Inventory     92,694       199,752  
Accounts payable and accrued liabilities     1,414,505       (916,927 )
                 
Cash flows from operating activities     (3,267,768 )     (5,123,908 )
                 
INVESTING ACTIVITIES                
                 
Purchase of property and equipment (Note 7)     (2,161,786 )     (293,290 )
Purchase of patents and licenses (Note 8)     (13,666 )     (31,522 )
                 
Cash flows from investing activities     (2,175,452 )     (324,812 )
                 
FINANCING ACTIVITIES                
                 
Cash from the exercise of units in a public offering, net of issue costs, and cash                
from the issue of common shares from the exercise of stock options and                
warrants, net of issue costs (Note 11).     10,581,150       102,045  
                 
Cash flows from financing activities     10,581,150       102,045  
                 
EFFECT OF EXCHANGE RATE CHANGES ON CASH     (121,403 )     135,859  
                 
NET CHANGE IN CASH     5,016,527       (5,210,816 )
CASH, beginning of period     4,974,478       14,376,282  
                 
CASH, end of period   $ 9,991,005     $ 9,165,466  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

Page 5

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

 

1. DESCRIPTION OF BUSINESS

 

POET Technologies Inc. is incorporated in the Province of Ontario. POET Technologies Inc. and its subsidiaries (the "Company") are developers and manufacturers of optical source products and photonic integrated devices for the sensing, datacom and telecom markets. The Company's head office is located at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada M4P 1E2. These consolidated financial statements of the Company were approved by the Board of Directors of the Company on August 15, 2018.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

These condensed unaudited consolidated financial statements of the Company and its subsidiaries were prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB").

 

These condensed unaudited interim consolidated financial statements do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated audited financial statements for the year ended December 31, 2017.

 

The preparation of financial statements in accordance with IAS 34 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:

 

Basis of presentation

These condensed unaudited consolidated financial statements include the accounts of POET Technologies Inc. and its subsidiaries; ODIS Inc. ("ODIS"), Opel Solar Inc., BB Photonics Inc., BB Photonics UK Limited (collectively "BB Photonics") and DenseLight Semiconductors Pte. Ltd ("DenseLight"). All intercompany balances and transactions have been eliminated on consolidation.

 

Business combinations

Acquisitions of businesses are accounted for using the acquisition method. The acquisition cost is measured at the acquisition date at the fair value of the consideration transferred, including all contingent consideration.

 

Subsequent changes in contingent consideration are accounted for through the condensed consolidated statements of operations and deficit and condensed consolidated statements of comprehensive loss in accordance with the applicable standards.

 

Goodwill arising on acquisition is initially measured at cost, being the difference between the fair value of the consideration transferred including the recognized amount of any non-controlling interest in the acquiree and the net recognized amount (generally fair value) of the identifiable assets and liabilities assumed at the acquisition date. If the net of the amounts of the identifiable assets acquired and liabilities assumed exceeds the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree and the fair value of the acquirer’s previously held interest in the acquiree (if any), the excess is recognized immediately in profit or loss as a bargain purchase gain.

 

Acquisition-related costs, other than those that are associated with the issue of debt or equity securities that the Company incurs in connection with a business combination, are expensed as incurred.

 

Foreign currency translation

These condensed unaudited consolidated financial statements are presented in U.S. dollars ("USD"), which is the Company's presentation currency.

 

Page 6

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Items included in the financial statements of each of the Company's subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity are recognized in the statement of operations and deficit.

 

Assets and liabilities of entities with functional currencies other than U.S. dollars are translated into the presentation currency at rates of exchange applicable at each reporting date, and the results of their operations are translated at average rates of exchange for the reporting period. The resulting translation adjustments are included in accumulated other comprehensive loss in shareholders' equity. Additionally, foreign exchange gains and losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive loss.

 

Financial Instruments

Financial instruments are required to be classified as one of the following: held-to-maturity; loans and receivables, fair value through profit or loss; available-for-sale or other financial liabilities.

 

The Company's financial instruments include cash, accounts receivable, accounts payable and accrued liabilities. The Company designated its cash as fair value through profit or loss and its accounts payable and accrued liabilities as other financial liabilities.

 

Fair value through profit or loss financial assets are measured at fair value with gains and losses recognized in operations. Financial assets, loans and receivables and other financial liabilities are measured at amortized cost. Available-for-sale financial assets are measured at fair value with unrealized gains and losses recognized in other comprehensive loss.

 

Fair value of a financial instrument is the amount of consideration that would be agreed upon in an arm’s length transaction between knowledgeable, willing parties who are under no compulsion to act. The fair value of a financial instrument on initial recognition is the transaction price, which is the fair value of the consideration given or received. Subsequent to initial recognition, the fair value of a financial instrument that is quoted in active markets is based on the bid price for a financial asset held and the offer price for a financial liability. When an independent price is not available, fair value is determined by using a valuation methodology that refers to observable market data. Such a valuation technique includes comparisons with a similar financial instrument where an observable market price exists, discounted cash flow analysis, option pricing models and other valuation techniques commonly used by market participants. If no reliable estimate can be made, the Company measures the financial instrument at cost less impairment as a last resort.

 

Accounts receivable

Accounts receivable are amounts due from customers from the sale of products or services in the ordinary course of business. Accounts receivable are classified as current (on the consolidated statements of financial position) if payment is due within one year of the reporting period date, and are initially recognized at fair value and subsequently measured at amortized cost.

 

The provision policy for doubtful accounts of the Company is based on the ageing analysis and management's ongoing evaluation of the recoverability of the outstanding receivables. A considerable amount of judgement is required in assessing the ultimate realization of these receivables, including the assessment of the creditworthiness and the past collection history of each customer. If the financial conditions of these customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. As at the balance sheet date, no provision was required for accounts receivable.

 

Page 7

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Inventory

Inventory consists of raw material inventory, work in process, and finished goods and are recorded at the lower of cost and net realizable value. Cost is determined on a first in first out basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventory to its present condition.

 

An assessment is made of the net realizable value of inventory at each reporting period. Net realizable value is the estimated selling price less the estimated cost of completion and the estimated costs necessary to make the sale. When circumstances that previously caused inventories to be written down no longer exist or when there is clear evidence of an increase in net realizable value because of changed economic circumstances, the amount of any write down previously recorded is reversed so that the new carrying amount is the lower of the cost and the revised net realizable value. Raw materials are not written down unless the goods in which they are incorporated are expected to be sold for less than cost, in which case, they are written down by reference to replacement cost of the raw materials, as this is the best indicator of net realizable value.

 

Property and equipment

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

 

Machinery and equipment   Straight Line, 5 years
Leasehold improvements   Straight Line, 5 years or life of the lease, whichever is less
Office and other equipment   Straight Line, 3 - 5 years

 

Patents and licenses

Patents and licenses are recorded at cost and amortized on a straight line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

 

Impairment of long-lived assets

The Company’s tangible and intangible assets are reviewed for indications of impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. An assessment is made at each reporting date whether there is any indication that an asset may be impaired.

 

An impairment loss is recognized when the carrying amount of an asset exceeds its recoverable amount. Impairment losses are recognized in profit and loss for the year. The recoverable amount is the greater of the asset’s fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit ("CGU") to which the asset belongs.

 

An impairment loss is reversed if there is an indication that there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Goodwill

Goodwill represents the excess of the cost of an acquired business over the fair value of the identifiable assets acquired net of liabilities assumed. Goodwill is measured at cost less accumulated impairment losses and is not amortized. Goodwill is tested for impairment on an annual basis or whenever facts or circumstances indicate that the carrying amount may exceed its recoverable amount.

 

Page 8

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Income taxes

The Company follows the liability method of accounting for income taxes. Under this method, deferred income taxes are provided on differences between the financial reporting and income tax bases of assets and liabilities and on income tax losses available to be carried forward to future years for tax purposes. Deferred income taxes are measured using the substantively enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. Valuation allowances are provided to reduce deferred income tax assets to the amount expected to be realized.

 

Recently Enacted U.S. Federal Tax Legislation

Introduced initially as the Tax Cuts and Jobs Act, the Act to Provide for Reconciliation Pursuant to Titles II and V of the Concurrent Resolution on the Budget for Fiscal Year 2018 (the “Act”) was enacted on December 22, 2017. The Act applies to corporations generally beginning with taxable years starting after December 31, 2017 and reduces the corporate tax rate from a graduated set of rates with a maximum 35% tax rate to a flat 21% tax rate. Additionally, the Act introduces other changes that impact corporations, including a net operating loss (“NOL”) deduction annual limitation, an interest expense deduction annual limitation, elimination of the alternative minimum tax, and immediate expensing of the full cost of qualified property. The Act also introduces an international tax reform that moves the U.S. toward a territorial system, in which income earned in other countries will generally not be subject to U.S. taxation. However, the accumulated foreign earnings of certain foreign corporations will be subject to a one-time transition tax, which can be elected to be paid over an eight-year tax transition period, using specified percentages, or in one lump sum. NOL and foreign tax credit (“FTC”) carryforwards can be used to offset the transition tax liability. The Company does not expect that this change will have an impact on the Company as it has not earned taxable income in the past and it has significant NOL carryforwards.

 

Revenue recognition

Sale of goods

Revenue from the sale of goods is recognized when control of the goods are transferred to the buyer, there is persuasive evidence of an arrangement, collection is probable and fees are fixed and determinable.

 

Service revenue

Revenue from services that are one year or less is recognized when the services are completed. Revenue from services of a long-term nature is recognized by reference to the stage of completion of the transaction at the end of the reporting period determined by services performed to date as a percentage of total services and the amount of revenue, stage of completion, and the costs incurred for the transaction and the costs to complete the transaction can be measured reliably.

 

The Company recently adopted IFRS 15 - Revenue from Contracts from Customers, further explained in Note 3 and 21.

 

Interest income

Interest income on cash classified as fair value through profit or loss is recognized as earned.

 

Other income

Government Grants

Grants received exclusively from governmental agencies such as the Productivity and Innovation Credit Scheme Singapore ("PIC Grant"), relating to research and development or expenditure on technology, are recognized as other income.

 

Page 9

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

PIC Grants are offered as a percentage of qualifying expenditures. PIC Grants are paid out in cash. Other income earned on government grants in 2018 was nil (2017 - nil).

 

Research and Development Credits

The Company is eligible to receive cash credits for certain qualifying research and development expenses based on actual spending over a three year period, with an expectation that the credits will not exceed a certain dollar value over the three year period. At June 30, 2018, the Company has a recoverable amount of $1,026,986 relating to these research and development credits (2017 - $1,287,539) and is classified as prepaid and other current assets. Qualifying recovery of $602,800 has been recorded for the period ended June 30, 2018 (2017 - nil) and is included in other income.

 

Intangible assets

Research and development costs

Research costs are expensed in the year incurred. Development costs are also expensed in the year incurred unless the Company believes a development project meets IFRS criteria as set out in IAS 38, Intangible Assets , for deferral and amortization. IAS 38 requires all research costs be charged to expense while development costs are capitalised only after technical and commercial feasibility of the asset for sale or use have been established. This means that the entity must intend and be able to complete the intangible asset and either use it or sell it and be able to demonstrate how the asset will generate future economic benefits. Development costs are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable.

 

In-Process Research and Development

Under IFRS, in-process research and development ("IPR&D") acquired in a business combination that meets the definition of an intangible asset is capitalized with amortization commencing when the asset is ready for use (i.e., when development is complete). The Company acquired $714,000 of IPR&D when it acquired BB Photonics Inc. in 2016. The development of this IPR&D is still incomplete, therefore no amortization has been charged against IPR&D.

 

Customer relationships

Intangible assets include customer relationships. Customer relationships is an externally acquired intangible asset and is measured at cost less accumulated amortization and any accumulated impairment losses. Customer relationships are amortized on a straight-line basis over their estimated useful lives and is tested for impairment whenever events or changes indicate that their carrying amount may not be recoverable. Customer relationships was acquired when the the Company acquired DenseLight in 2016. The useful life of customer relationships was determined to be 5 years.

 

Stock-based compensation

Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant.

 

Loss per share

Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period after giving effect to potentially dilutive financial instruments. The dilutive effect of stock options and warrants is determined using the treasury stock method.

 

Page 10

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

3. RECENT ACCOUNTING PRONOUNCEMENTS

 

Recently adopted accounting policy

IFRS 15, Revenue from Contracts with Customers ("IFRS 15"). The IASB issued IFRS 15, which is effective for annual periods beginning on or after January 1, 2018. The standard contains a single model that applies to contracts with customers and two approaches to recognizing revenue: at a point in time and over time. The model features a contract-based five-step analysis of transactions to determine whether, how much and when revenue is recognized. New estimates and judgmental thresholds have been introduced, which may affect the amount and/or timing of revenue recognized. The Company adopted the policy using the modified retrospective method (Note 21).

 

The following is a summary of recent accounting pronouncements that may affect the Company:

IFRS 16, Leases (“IFRS 16”) sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, the customer (lessee) and the supplier (lessor). This will replace IAS 17, Leases (“IAS 17”) and related Interpretations. IFRS 16 provides revised guidance on identifying a lease and for separating lease and non-lease components of a contract. IFRS 16 introduces a single accounting model for all lessees and requires a lessee to recognize right-of-use assets and lease liabilities for leases with terms of more than 12 months, unless the underlying asset is of low value, and depreciation of lease assets is reported separately from interest on lease liabilities in the income statement. Under IFRS 16, lessor accounting for operating and finance leases will remain substantially unchanged. IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with earlier application permitted for entities that apply IFRS 15, Revenue from Contracts with Customers. The Company is in the process of assessing the impact of this standard on its consolidated financial statements.

 

4. ACCOUNTS RECEIVABLE

 

The carrying amounts of accounts receivable approximate their fair value and are originally denominated in the following currencies before conversion to US dollars below:

 

        June 30,     December 31,  
        2018     2017  
                 
                 
Product sales   United States dollars   $ 393,077     $ 493,925  
Product sales   Singapore dollar     40,531       -  
                     
        $ 433,608     $ 493,925  

 

In determining the recoverability of a trade receivable, the Company considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the reporting date. The trade receivables that are neither past due nor impaired relates to customers that the company has assessed to be creditworthy based on the credit evaluation process performed by management which considers both customers' overall credit profile and its payment history with the Company.

 

5. PREPAIDS AND OTHER CURRENT ASSETS

 

The following table reflects the details of prepaids and other current assets:

 

    June 30,     December 31,  
    2018     2017  
             
Sales tax recoverable and other current assets   $ 173,330     $ 119,482  
Research and development credit     1,026,986       1,287,539  
Security deposits on leased properties     228,170       228,170  
Equipment and materials deposit     223,425       322,536  
                 
    $ 1,651,911     $ 1,957,727  

 

Page 11

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

6. INVENTORY

 

    June 30,     December 31,  
    2018     2017  
             
Raw materials   $ 103,411     $ 112,768  
Finished goods     189,476       260,105  
Work in process     131,626       151,709  
                 
    $ 424,513     $ 524,582  

 

7. PROPERTY AND EQUIPMENT

 

    Equipment not     Leasehold     Machinery and     Office        
    in service     improvements     equipment     equipment     Total  
Cost                                        
Balance, January 1, 2017   $ 602,830     $ 667,342     $ 9,734,885     $ 314,817     $ 11,319,874  
Additions     806,182       -       113,433       50,182       969,797  
Reclassification     (874,371 )     -       874,371       -       -  
Effect of changes in foreign                                        
exchange rates     46,433       -       72,779       8,914       128,126  
                                         
Balance, December 31, 2017     581,074       667,342       10,795,468       373,913       12,417,797  
Additions     2,161,786       -       -       -       2,161,786  
Reclassification     (648,455 )     -       608,113       40,342       -  
Effect of changes in foreign                                        
exchange rates     (59,686 )     -       (29,861 )     (1,739 )     (91,286 )
                                         
Balance,June 30, 2018     2,034,719       667,342       11,373,720       412,516       14,488,297  
                                         
Accumulated Depreciation                                        
Balance, January 1, 2017     -       83,189       1,808,308       64,167       1,955,664  
Depreciation for the year     -       133,499       1,857,474       192,990       2,183,963  
                                         
Balance, December 31, 2017     -       216,688       3,665,782       257,157       4,139,627  
Depreciation for the period     -       66,910       1,095,741       45,774       1,208,425  
                                         
Balance, June 30, 2018     -       283,598       4,761,523       302,931       5,348,052  
                                         
Carrying Amounts                                        
At December 31, 2017   $ 581,074     $ 450,654     $ 7,129,686     $ 116,756     $ 8,278,170  
At June 30, 2018   $ 2,034,719     $ 383,744     $ 6,612,197     $ 109,585     $ 9,140,245  

 

8. PATENTS AND LICENSES

 

       
Cost        
Balance, January 1, 2017   $ 609,887  
Additions     60,543  
         
Balance, December 31, 2017     670,430  
Additions     13,666  
         
Balance, June 30, 2018     684,096  
         
Accumulated Amortization        
Balance, January 1, 2017     160,211  
Amortization for the year     53,969  
         
Balance, December 31, 2017     214,180  
Amortization for the period     28,796  
         
Balance, June 30, 2018     242,976  

 

Page 12

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

8. PATENTS AND LICENSES (Continued)

 

Carrying Amounts

 

At December 31, 2017   $ 456,250  
         
At June 30, 2018   $ 441,120  

 

9. INTANGIBLE ASSETS

 

          Customer        
    Technology     Relationships     Total  
                   
Cost                        
Balance, December 31, 2017 and June 30, 2018   $ 714,000     $ 186,131     $ 900,131  
                         
Accumulated Amortization                        
Balance, January 1, 2017     -       23,266       23,266  
Amortization for the year     -       37,228       37,228  
                         
Balance, December 31, 2017     -       60,494       60,494  
Amortization for the period     -       18,614       18,614  
                         
Balance, June 30, 2018     -       79,108       79,108  
                         
Carrying Amounts                        
At December 31, 2017   $ 714,000     $ 125,637     $ 839,637  
                         
At June 30, 2018   $ 714,000     $ 107,023     $ 821,023  

 

 

10. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

    June 30,     December 31,  
    2018     2017  
             
Trade payable   $ 1,500,702     $ 504,229  
Payroll related liabilities     172,819       112,913  
Accrued liabilities     235,620       193,451  
                 
    $ 1,909,141     $ 810,593  

 

Page 13

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

11. SHARE CAPITAL

 

(a) AUTHORIZED

Unlimited number of common shares

One special voting share

 

(b) COMMON SHARES ISSUED

 

    Number of        
    Shares     Amount  
             
Balance, January 1, 2017     259,333,853       103,357,862  
Shares issued on the exercise of stock options     685,000       123,528  
Fair value of stock options exercised     -       134,831  
                 
December 31, 2017     260,018,853       103,616,221  
Shares issued on public offering     25,090,700       10,663,548  
Cost of shares issued on public offering     -       (1,193,144 )
Fair value of warrants issued     -       (2,286,426 )
Fair value of compensation options issued to brokers     -       (479,204 )
Fair value assigned to stock options exercised     347,250       82,275  
Fair value of stock options exercised     -       77,185  
Shares issued on the exercise of warrants     2,600,500       1,028,471  
Fair value of warrants exercised     -       447,270  
                 
Balance, June 30, 2018     288,057,303     $ 111,956,196  

 

On March 21, 2018, the Company completed a brokered "bought deal" public offering of 25,090,700 units at a price of $0.425 (CAD$0.55) per unit for gross proceeds of $10,663,548 (CAD$13,799,885). Each unit consists of one common share and one-half common share purchase warrant. Each whole warrant entitles the holder to purchase one common share of the Company at a price of $0.58 (CAD$0.75) per share until March 21, 2020. The broker was paid a cash commission of $639,813 (6%) of the gross proceeds and received 1,505,442 compensation options. Each compensation option is exercisable into one compensation unit of the Company at a price of $0.425 (CAD$0.55) per compensation unit until March 21, 2020 with each compensation unit comprising one common share and one-half compensation share purchase warrant. Each whole compensation share purchase warrant entitles the broker to purchase one common share of the Company at a price of $0.425 (CAD$0.55) per share until March 21, 2020. The Company paid or accrued an additional $553,331 in other costs related to this financing.

 

Certain management participated in the “bought-deal” public offering, by acquiring 281,000 units at a price of $0.425 (CAD$0.55) per unit for gross proceeds of $119,425 (CAD$154,550).

 

The fair value of the share purchase warrants and compensation options was estimated using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk-free interest rate of 1.86%, volatility of 94.77%, and estimated life of 2 years. The estimated fair values assigned to the warrants and compensation options were $2,286,426 and $479,204 respectively.

 

12. WARRANTS AND COMPENSATION OPTIONS

 

The following table reflects the continuity of warrants and compensation options:

 

          Number of        
    Average Exercise     Warrants and     Historical  
    Price     Compensation Options     Fair value  
                   
Balance, January 1, 2017 and December 31, 2017   $ 0.39       34,800,000     $ 5,985,378  
Fair value of warrants issued on public offering     0.57       12,545,350       2,286,426  
Historical fair value assigned to warrants exercised     0.39       (2,600,500 )     (447,270 )
Fair value of compensation options issued to brokers     0.42       1,505,442       479,204  
                         
Balance, June 30, 2018   $ 0.42       46,250,292     $ 8,303,738  

 

Page 14

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

13. STOCK OPTIONS AND CONTRIBUTED SURPLUS

 

Stock Options

On June 21, 2018, shareholders of the Company approved amendments to the Company's fixed 20% stock option plan (as amended, referred to as the "2018 Plan"). Under the 2018 Plan, the board of directors may grant options to acquire common shares of the Company to qualified directors, officers, employees and consultants. The 2018 Plan provides that the number of common shares issuable pursuant to options granted under the 2018 Plan and pursuant to other previously granted options is limited to 57,611,360 (the “Number Reserved”). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. The stock options vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the 2018 Plan which grants discretion to the Board of Directors.

 

Stock option transactions and the number of stock options outstanding were as follows:

 

          Weighted average  
    Number of     Exercise  
    Options     Price  
             
Balance, January 1, 2017     23,805,500     $ 0.96  
Expired/cancelled     (5,455,209 )     0.73  
Exercised     (685,000 )     0.19  
Granted     15,425,000       0.24  
                 
Balance, December 31, 2017     33,090,291       0.68  
Expired/cancelled     (869,791 )     1.12  
Exercised     (347,250 )     0.26  
Granted     10,425,479       0.35  
                 
Balance, June 30, 2018     42,298,729     $ 0.60  

 

During the period six months ended June 30, 2018, the Company granted 10,425,479 (Six months ended June 30, 2017 - 4,225,000) stock options to officers, employees and consultants of the Company to purchase common shares at an average price of $0.35 (Six months ended June 30, 2017 - $0.28) per share.

 

During the six months ended June 30, 2018, the Company recorded stock-based compensation of $1,855,895 (Six months ended June 30, 2017 - $1,054,596) relating to stock options that vested during the period.

 

The stock options granted were valued using the Black-Scholes option pricing model using the following assumptions:

 

    Six Months Ended  
    June 30,  
    2018     2017  
                 
Weighted average exercise price   $ 0.35     $ 0.28  
Weighted average risk-free interest rate     2.10 %     1.73 %
Weighted average dividend yield     0 %     0 %
Weighted average volatility     103.83 %     103.48 %
Weighted average estimated life     10 years       10 years  
Weighted average share price   $ 0.35     $ 0.28  
                 
Share price on the various grant dates were:                
                 
First grant   $ 0.18     $ 0.32  
Second grant     0.23       0.27  
Third grant     0.40       0.25  
Fourth grant     0.25       0.28  
Fifth grant     -       0.22  

 

The underlying expected volatility was determined by reference to the Company's historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options.

 

Page 15

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

13. STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)

 

The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at June 30, 2018 are as follows:

 

Options Outstanding     Options Exercisable  
                               
                Weighted              
          Weighted     Average     Weighted        
          Average     Remaining     Average        
Exercise   Number     Exercise     Contractual     Number     Exercise  
Range   Outstanding     Price     Life (years)     Exercisable     Price  
                               
$0.11 - $0.21     693,750     $ 0.19       7.64       342,188     $ 0.21  
$0.22 - $0.25     10,133,750     $ 0.22       9.05       2,687,500     $ 0.22  
$0.26 - $0.37     3,949,499     $ 0.26       9.62       168,750     $ 0.26  
$0.38 - $0.86     15,039,730     $ 0.42       8.41       3,609,621     $ 0.45  
$0.87 - $1.64     12,482,000     $ 1.24       1.79       10,215,241     $ 1.28  
                                         
      42,298,729     $ 0.60       6.71       17,023,300     $ 0.90  

 

Contributed Surplus

 

The following table reflects the continuity of contributed surplus:

 

    Amount  
       
Balance, January 1, 2017   $ 29,062,874  
Stock-based compensation     3,174,924  
Fair value of stock options exercised     (134,831 )
         
Balance, December 31, 2017     32,102,967  
Stock-based compensation     1,855,895  
Fair value of stock options exercised     (77,185 )
         
Balance, June 30, 2018   $ 33,881,677  

 

14. LOSS PER SHARE

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Numerator                                
Net loss   $ (4,613,007 )   $ (2,826,774 )   $ (7,787,814 )   $ (6,342,937 )
                                 
Denominator                                
Weighted average number of                                
common shares outstanding     288,056,802       259,800,132       275,893,767       259,566,993  
Weighted average number of common                                
shares outstanding - diluted     288,056,802       259,800,132       275,893,767       259,566,993  
                                 
Basic and diluted loss per share   $ (0.02 )   $ (0.01 )   $ (0.03 )   $ (0.02 )

 

The effect of common share purchase options, warrants and compensation options on the net loss in 2018 and 2017 is not reflected as they are anti-dilutive.

 

Page 16

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

15. COMMITMENTS AND CONTINGENCIES

 

The Company has operating leases on three facilities; head office located in Toronto, Canada, design and testing operations located in San Jose, California and operating facilities located in Singapore. The Company's design and testing operations terminated a lease on January 31, 2017 and initiated a new lease an February 1, 2017 which expires on January 31, 2020. The lease on the Company's operating facilities expires on February 15, 2019. As at December 31, 2017, the Company's head office was on a month to month lease term.

 

Rent expense under these leases was $114,561 and $229,122 respectively for the three and six months ended June 30, 2018 (2017 - $107,273 and $213,626).

 

Remaining minimum annual rental payments to the lease expiration date is as follows:

 

July 1, 2018 to June 30, 2019   $ 286,406  
July 1, 2019 through 2020     26,740  
         
    $ 313,146  

 

16. RELATED PARTY TRANSACTIONS

 

Compensation to key management personnel were as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Salaries   $ 284,584     $ 218,500     $ 546,667     $ 487,133  
Share-based payments (1)     728,148       557,345       1,200,217       1,280,798  
                                 
Total   $ 1,012,732     $ 775,845     $ 1,746,884     $ 1,767,931  

 

(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various periods as calculated using the Black-Scholes model.

 

The Company paid or accrued $29,379 and $59,045 in fees for the three and six months ended June 30, 2018 (2017 - $28,313 and $55,556) to a law firm, of which a director is counsel, for legal services rendered to the Company.

 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

 

Page 17

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

17. SEGMENT INFORMATION

 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semi-conductor products and services for commercial applications. The Company’s operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:

 

ODIS

ODIS is the developer of the POET platform semiconductor process IP for fabrication of integrated circuit devices containing both electronic and optical elements on a single die ("monolithic integration") and in a single package ("hybrid integration").

 

BB Photonics

BB Photonics develops photonic integrated components for the datacom and telecom markets utilizing embedded dielectric technology that enables the low-cost integration of active and passive devices into photonic integrated circuits.

 

DenseLight

DenseLight designs, manufactures, and delivers photonic optical light source products and packaging solutions to the communications, medical, instrumentation, industrial, and security industries. DenseLight processes III-V based optoelectronic devices and photonic integrated circuits through its in-house wafer fabrication and assembly & test facilities.

 

On a consolidated basis, the Company operates geographically in Singapore, the United States and Canada. Geographical information is as follows:

 

    2018  
                         
As of June 30,     Singapore       US       Canada       Consolidated  
Current assets   $ 2,569,804     $ 1,569,108     $ 8,362,125     $ 12,501,037  
Property and equipment     8,917,426       222,819       -       9,140,245  
Patents and licenses     18,196       422,924       -       441,120  
Goodwill and intangibles assets     6,737,567       1,764,459       -       8,502,026  
                                 
Total Assets   $ 18,242,993     $ 3,979,310     $ 8,362,125     $ 30,584,428  

    

                         
For the Six Months Ended June 30,   Singapore     US     Canada     Consolidated  
Sales   $ (1,425,427 )   $ -     $ -     $ (1,425,427 )
Cost of sales     588,117       -       -       588,117  
Selling, marketing and                                
administration     2,517,806       2,571,098       494,589       5,583,493  
Research and development     1,676,887       1,914,047       205,558       3,796,492  
Other income including                                
Investment income     (605,891 )     -       -       (605,891 )
                                 
Net loss from operations   $ 2,751,492     $ 4,485,145     $ 700,147     $ 7,936,784  

 

Page 18

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

17. SEGMENT INFORMATION (Continued)

 

    2017  
                         
As of December 31,     Singapore       US       Canada       Consolidated  
Current assets   $ 3,190,298     $ 4,621,318     $ 139,096     $ 7,950,712  
Property and equipment     8,018,900       259,270       -       8,278,170  
Patents and licenses     18,816       437,434       -       456,250  
Goodwill and intangible assets     6,756,181       1,764,459       -       8,520,640  
                                 
Total Assets   $ 17,984,195     $ 7,082,481     $ 139,096     $ 25,205,772  

 

                         
For the Six Months Ended June 30,   Singapore     US     Canada     Consolidated  
Sales   $ (1,360,932 )   $ -     $ -     $ (1,360,932 )
Cost of sales     609,048       -       -       609,048  
General and administration     1,464,967       3,047,999       410,511       4,923,477  
Research and development     1,119,598       1,251,517       111,563       2,482,678  
Other income     (145,044 )     (2,395 )     (14,925 )     (162,364 )
                                 
Net loss from operations   $ 1,687,637     $ 4,297,121     $ 507,149     $ 6,491,907  

 

 

18. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Company's financial instruments consist of cash, short-term investments, accounts receivable, and accounts payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that the fair value of these instruments approximates fair value due to their short term nature.

 

The Company has classified financial assets and (liabilities) as follows:

 

    June 30,     December 31,  
    2018     2017  
             
Fair value through profit or loss, measured at fair value:                
Cash   $ 9,991,005     $ 4,974,478  
Loans and receivable, measured at amortized cost:                
Accounts receivable     433,608       493,925  
Other liabilities, measured at amortized cost:                
Accounts payable and accrued liabilities     (1,909,141 )     (810,593 )

 

Financial instruments recorded at fair value on the balance sheet are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

 

Level 1 - valuation based on quoted prices (unadjusted) observed in active markets for identical assets or liabilities.

Level 2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly.

Level 3 - valuation techniques based on inputs for the asset or liability that are not based on observable market data.

 

Cash was determined using level 1 inputs. Short-term investments were determined using level 2 inputs.

 

Page 19

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

18. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued)

 

Credit Risk

The Company is exposed to credit risk associated with its accounts receivable. The Company has accounts receivable from both governmental and non-governmental agencies. Credit risk is minimized substantially by ensuring the credit worthiness of the entities with which it carries on business. Credit terms are provided on a case by case basis. The Company has not experienced any significant instances of non-payment from its customers.

 

The Company's accounts receivable ageing was as follows:

 

    June 30,     December 31,  
    2018     2017  
             
Current   $ 349,831     $ 330,731  
31 - 60 days     9,976       56,094  
61 - 90 days     -       -  
> 90 days     73,801       107,100  
                 
    $ 433,608     $ 493,925  

 

Exchange Rate Risk

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled. Functional currencies include the US, Singapore and Canadian dollar. Most transactions within the entities are conducted in functional currencies. As such, none of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk with the Canadian and Singapore dollar. A 10% change in the Canadian and Singapore dollar would increase or decrease other comprehensive loss by $914,100.

 

Liquidity Risk

The Company currently does not maintain credit facilities. The Company's existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the issuance of these unaudited condensed consolidated financial statements.

 

19. CAPITAL MANAGEMENT

 

In the management of capital, the Company includes shareholders' equity (excluding accumulated other comprehensive loss and deficit), cash and short-term investments. The components of capital on June 30, 2018 were:

 

Cash   $ 9,991,005  
Shareholders' equity   $ 154,141,611  

 

The Company's objective in managing capital is to ensure that financial flexibility is present, a) to increase shareholder value through growth; b) to respond to changes in economic and/or market conditions; c) to maintain a strong capital base so as to retain investor, creditor and market confidence; d) to sustain future development of the business; and e) to safeguard the Company's ability to obtain financing should the need arise.

 

In maintaining its capital, the Company has a strict investment policy which includes investing its surplus capital only in highly liquid, highly rated financial instruments.

 

The Company reviews its capital management approach on an ongoing basis.

 

Page 20

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

20. EXPENSES

 

Research and development costs can be analysed as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Wages and benefits   $ 1,103,788     $ 543,365     $ 1,984,253     $ 1,098,144  
Supplies     711,898       204,213       1,035,891       391,147  
Subcontract fees     83,878       438,464       517,629       843,754  
Stock-based compensation     147,012       58,216       258,719       149,633  
                                 
    $ 2,046,576     $ 1,244,258     $ 3,796,492     $ 2,482,678  

 

 

Selling, marketing and administration costs can be analysed as follows:

 

Stock-based compensation   $ 916,761     $ 101,567     $ 1,597,176     $ 904,963  
Depreciation and amortization     659,820       558,919       1,255,835       1,099,312  
Wages and benefits     620,696       604,608       1,242,470       1,250,488  
Rent and facility costs     270,456       266,679       513,186       544,993  
General expenses     229,560       387,254       506,211       655,992  
Professional fees     188,560       167,726       386,326       323,468  
Management and consulting fees     32,104       40,330       82,289       144,261  
                                 
    $ 2,917,957     $ 2,127,083     $ 5,583,493     $ 4,923,477  

 

21. REVENUE

 

On January 1, 2018, the Company adopted IFRS 15 - Revenue from Contracts with Customers , using the modified retrospective method. The adoption of this standard did not impact the timing of revenue recognition for customer sales prior to fiscal 2018.

 

Disaggregated Revenues

The Company disaggregagtes revenue by timing of revenue recognition, that is, at a point in time and revenue over time. Disaggregated revenue is as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
                         
Non-contract revenue (at a point in time)(1)   $ 677,198     $ 648,382     $ 1,350,427     $ 1,280,932  
Contract revenue (revenue over time)(2)     75,000       -       75,000       80,000  
                                 
    $ 752,198     $ 648,382     $ 1,425,427     $ 1,360,932  

 

(1) Revenue from the sale of products

(2) Revenue from non-recurring engineering (NRE)

 

Page 21

POET TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Expressed in US Dollars)

21. REVENUE (Continued)

 

Revenue Contract Balances

 

    Contract  
    Receivables     Liabilities  
             
Opening balance, January 1, 2017   $ -     $ 20,000  
Revenues recognized     80,000       (80,000 )
Changes due to payment, fulfillment of performance obligations                
or other     (40,000 )     60,000  
                 
Opening balance, December 31, 2017     40,000       -  
Revenues recognized     75,000       (75,000 )
Changes due to payment, fulfillment of performance obligations                
or other     (115,000 )     75,000  
                 
Balance, June 30, 2018   $ -     $ -  

 

The timing and satisfaction of the the Company's performance obligations under contracts with customers is generally in line with the timing of payments from customers, as a result the Company will not have material contract assets or liabilities.

 

Performance Obligations

 

The Company typically satisfies its performance obligations when services are rendered or products are delivered and accepted by the customer. Consideration is fixed and payment terms are consistent with the Company's terms for the sale of its products.

 

The aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied as of June 30, 2018 was $125,000. The Company expects to satisfy this amount over the next 12 months.

 

Judgements were used in determining the amount and timing of revenue from contracts with customers. The timing of satisfaction of performance obligations was determined by the delivery of products or services that met the customer's expectations. The transaction price and the amount allocated to performance obligations was determined using market rates that would be reasonable for the services or products provided.

 

 

 

Page 22

 

Exhibit 99.2

 

 

 

 

 

 

 

 

 

 

 

 

POET

TECHNOLOGIES INC.

 

 

 

 

 

Management’s Discussion

and Analysis

For the Three and Six Months Ended June 30, 2018

 

 

 

 

 

 

 

 

 

POET Technologies Inc.

Suite 1107 – 120 Eglinton Avenue East

Toronto, Ontario, Canada M4P 1E2

Tel: (416) 368-9411 Fax: (416) 322-5075

 

Management’s Discussion and Analysis

For the three and Six Months Ended June 30, 2018

 

The following discussion and analysis of the operations, results, and financial position of POET Technologies Inc., (the “Company” or “POET”) for the three and six months ended June 30, 2018 (the “Period”) should be read in conjunction with the Company’s unaudited condensed consolidated financial statements for the three and six months ended June 30, 2018 and the related notes thereto, both of which were prepared in accordance with International Financial Reporting Standards (“IFRS”). The effective date of this report is August 15, 2018. All financial figures are in United States dollars (“USD”) unless otherwise indicated. The abbreviation “U.S.” used throughout refers to the United States of America.

 

Forward-Looking Statements

 

This management discussion and analysis contains forward-looking statements that involve risks and uncertainties. It uses words such as “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, and other similar expressions to identify forward-looking statements. Forward-looking statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements, including, without limitation, risks and uncertainties relating to the early stage of the Company’s development and the possibility that future development of the Company’s technology and business will not be consistent with management’s expectations, difficulties in achieving commercial production or interruptions in such production if achieved, inherent risks of operating a manufacturing facility, including risks associated with supplier delays, factory uptime, inventory management and other operating uncertainties, the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, the uncertainty of profitability and failure to obtain adequate financing on a timely basis. The Company undertakes no obligation to update forward-looking statements if circumstances or Management’s estimates or opinions should change, except to the extent required by law. The reader is cautioned not to place undue reliance on forward-looking statements.

 

The Company is incorporated under the laws of the Province of Ontario. The Company’s shares trade under the symbol “PTK” on the TSX Venture Exchange in Canada and under the symbol “POETF” on the OTCQX in the U.S.

 

 

  1  

 

BUSINESS

 

Overview

 

We are an advanced semiconductor development and manufacturing company dedicated to enabling the integration of photonics and electronics through novel approaches to device design and packaging. We have developed, or are in the process of developing, solutions that provide dramatic reductions in the cost of key components of photonic devices. Through integration and the adaptation of silicon processing methods to photonic device fabrication, we believe that the Company can capture a meaningful portion of the market for photonics devices that address the need for increased bandwidth, speed, sensitivity and cost across a range of high growth data communications and photonic sensing applications. We believe that the integration of discrete functions onto fewer devices is the optimal way to lower cost, reduce size, limit power consumption and increase the performance, scalability and value of photonics devices, making opto-electronics a more viable economic proposition.

 

The cost of building silicon-based devices today contrasts sharply with the cost of building photonics-based devices. While the majority of the cost of building silicon-based devices is in fabricating the device on the wafer, the majority of the cost of building photonics devices today is in the packaging and testing process. It is inevitable that these costs will be reduced through integration. In addition, integration opens up entirely new markets for photonics, including on-board and on-chip data transfer (“inside the box”).

 

Until early to mid-2017, our Company had been focused on “monolithic” integration, based on a proprietary design fabricated into a single Gallium Arsenide (GaAs) chip that has all of the elements needed to communicate data at the speed of light, yet with the lower cost profile of copper. POET’s GaAs design integrates at least three essential discrete devices onto a single GaAs chip: a vertical-cavity surface-emitting laser (VCSEL), a photodetector and an electronic circuit based on either a thyristor or a heterostructure field-effect transistor (HFET).

 

In 2017 we began to develop solutions based on a novel “hybrid” integration approach, which combines Indium Phosphide (InP)-based photonics chips and dielectric-based waveguide devices into a single package. This approach enables the replacement of high-cost optical components, such as mirrors and lenses, with embedded dielectric passive devices, dramatically lowering the cost of data communications transceiver solutions for data center operators and telecom companies. Our ability to address hybrid integration is a direct result of our acquisitions, in 2016, of DenseLight Semiconductor Pte. Ltd. (“DenseLight”) based in Singapore, and BB Photonics, Inc. based in New Jersey.

 

By mid-2017 it became apparent that the majority of transceiver applications in the data center market was biased strongly in favor of InP-based solutions. This, and the fact that our GaAs development efforts faced a number of challenges that could only be solved by working closely with a well-resourced strategic partner, we decided to focus our own resources on hybrid integration, utilizing the unique capabilities that we acquired with DenseLight and BB Photonics. By late-2017, we demonstrated that we could dramatically reduce the cost of conventional transceivers through the integration of discrete devices employing a novel approach that we call an “Optical Interposer”.

 

POET’s Optical Interposer Ô facilitates the co-packaging of electronics and optics in a single Multi-Chip Module (MCM), paving the way for “Photonics-in-a-package”. Based on our dielectric waveguide technology, the Optical Interposer provides the ability to run electrical and optical interconnections side-by-side on the same interposer chip at a micrometer scale. Hybrid Integrated Photonics Packaging (HiPP) enabled by the Optical Interposer plays a critical role in improving electrical and thermal performance, power consumption and form factor of photonics sub-assemblies. The Optical Interposer currently forms an integral part of POET’s hybrid integrated Optical Engine and leverages the manufacturing processes and unique capabilities of its dielectric waveguides.

 

  2  

 

Industry Background

 

Since the introduction of the smartphone, people have fundamentally changed the way they communicate, socialize, and interact among themselves and the data around them. Today, smartphones and other such devices allow us to capture, create and communicate enormous amounts of content. The explosion in data, storage and information distribution is driving extraordinary growth in internet traffic and cloud services. The expected growth in the networking and data communication market is the result of many factors, among them being, the growth of wireless and mobile traffic (which will account for two-thirds of total IP traffic by 2021 1 ), social media activity, the progression of video transmission, the emergence of imaging such as virtual/augmented/mixed reality and 3D video, the continued migration to cloud storage, the propagation of sensors feeding the Internet of Things, and the evolution of big data analytics and machine learning/artificial intelligence. These factors will continue to drive a long term increased demand for capacity and higher speeds.

 

Photonics has traditionally been employed to receive data over long distances because light can carry considerably more content and data at faster speeds than other means of transmission, such as radio waves or copper wires. Optical transmission becomes more energy efficient as compared to electronic alternatives when the transmission length and speed increase. As a natural consequence, optics are systematically replacing copper in many of the data center communication links where speed, bandwidth and energy are at a premium.

 

Data center operators are increasing the size and scale of their facilities, while simultaneously looking to component suppliers for solutions capable of providing higher data transmission rates. Within data centers, data communications over distances of up to 2 km have already been transitioned from inherently lower speed copper cable to optical fibers. Furthermore, short reach communications, either rack-to-rack or within the rack as well as those requiring speeds of up to 100G, are now increasingly being converted from copper to optical cables.

 

Outside the Data Centers, future 5G build-out of mobile communications will drive speed and capacity requirements closer to the user with significant reduction in latency. Compared to 4G, 5G technology standard offers much faster download and upload speed, minimum delay in data communication and processing, as well as much higher density in device connections. 5G will enable advances in virtual reality, augmented reality, autonomous driving, high-definition video, and the Internet of Things, among other applications. All of these applications require advanced photonics devices to provide higher speeds and more bandwidth.

 

Photonics Markets

 

The two target markets in which we currently sell or plan to sell products near-term are Photonic Sensing and Data Communications. The global photonics market is forecasted to grow at a compound average growth rate (CAGR) of 8% to 12% through 2021, reaching an estimated $54 billion. 2 This market includes Photonic Sensing (which consists of devices for test and measurement, navigation, LIDAR systems) and Data Communications (both telecom applications and optical data communications).

__________________

1 Cisco Visual Networking Index: Forecast and Methodology, 2016-2021 , June 6, 2017

2 MarketsandMarkets Photonics Market by Application – Global Forecasts to 2021 , September 2016

  3  

 

The growth of the overall Data Communications market is forecasted to grow at a 27% CAGR over the period from 2015 to 2020 and is being driven largely by cloud data centers, which have a forecasted CAGR of 29.6% over the same period. This compares to traditional data centers at only a 9% CAGR 3 . Within the overall Data Communications market, photonic transceivers will represent a $25 billion market opportunity in 2025, according to Oculi, llc . The primary segments for photonic transceivers are Ethernet, wide area network (WAN) and dense wavelength division multiplexing (DWDM), all of which are predominantly addressed by InP-based optical technologies. Ethernet transceivers are forecasted to grow to $7.4 billion by 2025 with 100G driving a majority of the growth. Within Ethernet, singlemode transceivers based on InP devices are forecasted to outgrow multimode transceivers based on GaAs devices by a factor of 6:1. Segmented by distance, the majority of growth is expected in the <10km segment ($4.3 billion by 2025) . 4

 

Integrated photonic transceivers, incorporating approaches comparable to that of POET, are expected to overtake those using discrete components by 2021, growing from a current $3.2 billion to $20 billion in 2025 5 . Within this market, POET is focused on the highest growth segments, including Wavelength Division Multiplexing (WDM) for medium-reach (500m – 2km) Ethernet datacom connections and Wide Area Network protocols for long-reach or metro applications (2km – 10km). The majority of today’s discrete transceiver suppliers are shipping 100G transceivers in a 4x25G format, having developed assembly methods for placing multiple laser chips on one substrate and coupling the output into one fiber using micro-optic filters and other elements. POET’s approach is to use the Optical Interposer to combine multiple active and passive devices into a single package, or “Optical Engine”, which when combined with control electronics and an outer housing, constitutes a pluggable optical transceiver. We plan to sell our Optical Engines to manufacturers and assemblers of optical transceiver modules. We believe our Optical Engine solution will be cost competitive with conventional modules as well as silicon photonics in the <2km data center market, and it should be scalable to 10km, and support 200G and 400G datacom speeds.

 

In addition to building Optical Engines for transceivers, we believe the Company has the opportunity to sell individual components to other suppliers of optical transceivers, including single-chip local area network (LAN) wavelength division multiplexing (WDM) lasers, Receive Optical Engines for receive optical sub-assemblies (ROSA) in advance of selling Optical Engines for transmit and receive assemblies (TXRX).

 

The Photonics Sensing market 6 represents a Total Available Market (“TAM”) of approximately $23 billion of system sales and comprises the following segments: 1) Test & Measurement (TAM: $10 billion), which includes monitoring equipment for communication, components and material testing, as well as sensing equipment such as distributed temperature and strain measurement; 2) Structural Health Monitoring (TAM: $6 billion), which includes devices to monitor the power grid, and fiber optic-based sensors in rail lines, nuclear facilities, etc.; 3) Guidance and Navigation (TAM: $4.5 billion), which includes navigational guidance systems, gyrocompasses, and optical-based systems for navigating self-driving automobiles; and 4) Medical and Health Care (TAM: $2.5 billion), which includes devices for non-invasive blood glucose monitoring, pulse-oximeter devices, and ophthalmic examination. Component sales to systems providers typically represent approximately 10% of system market TAM’s. We plan to address these high growth markets with component sales in a combination of current and expected new products from our DenseLight subsidiary.

 

__________________

3 Cisco Global Cloud Index, 2015-2020 , November 2016

4 Oculi, llc, Estimates for 2025 commissioned by POET Technologies, Inc. , March 2017

5 Ibid

6 Global Market Insights Optical Sensors Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024 , August 2016

  4  

 

POET’s Optical Interposer Platform

 

The POET Optical Interposer extends the functionality of traditional electrical interposers by adding a parallel lane of optical interconnections to an electrical interposer. Optical Interposers enable the concept of “photonics-in-a-package” by eliminating traditionally used micro-optics such as lenses, filters and prisms from the optical assembly and by further simplifying fiber alignment and coupling.

 

POET’s Optical Interposer utilizes our proprietary dielectric waveguide technology. The unique manufacturing process and capabilities of this technology enables us to fabricate an optical communication fabric within the context of a traditional CMOS process. Consequently, it enables a novel and differentiated extension to the more traditional electrical interposers.

 

The waveguides incorporated in POET’s Optical Interposers perform more than just waveguide transmission functions. They act as gratings, splitters, couplers and allow for manipulation of the light with built in functionality suited to the application. For example, POET’s 100G family of Optical Interposer will include gratings that both function to enable narrow line width operation of its light sources and to perform critical Wavelength Division Multiplexing (WDM) operations.

 

A Typical Electrical Interposer

 

 

Shown above is a typical cross-section of an electrical interposer that enables a closer placement of electronic chips and minimizes communication lengths.

 

POET’s Optical Interposer

 

 

In much the same way as the electrical interposer incorporates electrical passive functionality, the POET Optical Interposer incorporates passive optical functionality. Furthermore, the Optical Interposer enables the conversion of electrical signals to optical signals and the manipulation and transmission of these optical signals outside the package.

 

  5  

 

POET’s Optical Interposer provides the following advantages compared to conventional optical modules:

 

ü Wafer-level integration into silicon

 

ü Waveguides formed and integrated with embedded passive optical components (SSC, mux-demux, filters, waveguides) at chip level

 

ü Ultra-low loss waveguide dielectric with high coupling efficiency

 

ü Pick and place assembly and passive alignment of components

 

ü Elimination of lenses and active alignment

 

ü Athermal waveguide dielectric allows multi-channel scalability

 

ü Wafer-level hermetic sealing, testing and burn-in of active components to produce known good die

 

ü Small form factor and platform architecture readily scalable

 

ü High frequency metal traces managed in the dielectric platform

 

ü Fully compatible with conventional CMOS processing allowing integration with complex electronics at chip or module level

 

Compared to semiconductors, where packaging accounts for 10% of the final die cost, packaging, testing and assembly is generally 80-90% for a photonic die. By utilizing 2D and 3D chip-level manufacturing techniques proven in semiconductors, POET’s Optical Interposer dramatically lowers the cost of packaging, testing and assembly, representing a completely new and potentially disruptive approach to photonics device production. In addition, POET’s innovative, Multi-Chip-Module approach to packaging and assembly allows for more functionality to be integrated into a single package, analogous to the system-in-package (SiP) trends observable in the industry today.

 

Our Strategy

 

Our vision is to become a global leader in photonics by deploying an Optical Interposer-based approach to the integration of photonics devices into a wide variety of vertical market applications. Our strategy includes the following key elements:

 

· Introduce the Optical Interposer concept to suppliers of transceivers and data center operators and form commercial partnerships for product development. Because of the magnitude of the cost savings that may be derived from the use of POET’s Optical Engines for transceiver applications, we expect to generate significant interest among both the suppliers of transceiver modules and their ultimate customers, the data center operators. In addition, the POET Optical Interposer provides a straightforward and cost-effective path to higher speed transceivers, including up to 400G and higher, thus providing a single platform that can span several device generations. We anticipate that several companies will be interested in pursuing commercial partnerships with POET in order to qualify and design-in our Optical Engines.

 

  6  

 

· Promote the POET Optical Interposer as a true platform technology across several photonic applications and markets. The POET Optical Interposer is designed to be a flexible platform for the combination or integration of various photonic and electronic components. The anticipated low cost makes it suitable for applications like automotive LIDAR. The compatibility of the Optical Interposer manufacturing process with standard silicon CMOS processing opens up a wide variety of other applications where high-speed data communications is needed, such as integration with ASICs, graphics generators and high-speed switches.

 

· Pursue multiple potential sources of non-product revenue and strategic partnerships. In addition to product sales, we have been pursuing Non-Recurring Engineering (“NRE”) revenues from end-use customers and/or from strategic partners. In particular, we believe our 100/200/400G transceiver components represent a uniquely attractive opportunity for collaborative development with a strategic partner(s). We also believe that the continued development of our GaAs platform is dependent on securing a strategic partner.

 

· Continue to invest in our capabilities and infrastructure. We intend to continue to invest in new products, new technology and our production infrastructure and facilities to maintain and strengthen our competitive position. Our R&D programs in Singapore are partially reimbursed by the Singapore Economic Development Board, whose support will help to defer the costs associated with bringing innovative new products to market.

 

· Selectively pursue other opportunities that leverage our existing expertise. Our expertise in designing and manufacturing photonics devices, both discrete and integrated, positions us well to pursue applications in high growth markets and our Singapore operation is ideally located to support customers in Asia, where much of the growth in photonics is occurring.

 

· Pursue complementary strategic alliance or acquisition opportunities . We intend to evaluate and selectively pursue strategic alliances or acquisition opportunities that we believe will accelerate our penetration of specific applications or vertical markets with our technology or products.

 

Our Products

 

· We are currently engaged in the development of 100Gbs Receive Optical Engines and Transmit Optical Engines for 100Gbs Transceiver assemblies.

 

We expect our InP-based solutions from our DenseLight subsidiary will add to the Company’s current and future product portfolio, including:

 

· Broadband Super-Luminescent LEDs (Light Emitting Diodes)
· Narrow Linewidth Lasers
· DFB (Distributed Feedback) Lasers for Data Communications
· High Power ELEDs (Edge Emitting Light Emitting Diodes)
· Integrated CWDM (Coarse Wavelength Division Multiplexing) Solutions

 

Intellectual Property

 

We have 59 issued patents and 10 patent applications pending, including seven related to our optical interposer platform. The patents cover device structures, underlying technology, applications of the technology and fabrication processes. We believe these patents provide a significant barrier to entry against competition, along with trade secrets and know-how acquired from DenseLight and BB Photonics. We intend to continue to apply for additional patents in the future. Currently, we are working on the design of integrated devices, manufacturing processes, and products for data communication applications in the data center market, along with products for photonic sensing markets that employ novel packaging technologies.

 

  7  

 

Fabrication and Assembly Capabilities

 

We provide one-stop design and manufacturing solutions, from photonics design and simulation, epitaxial growth, wafer fabrication, chip production, in-line optical coating, sub-mounting, photonic measurements, product testing and screening. We are operationally ready for responsive prototyping and quality production. The 50,000 sq. ft. purpose-built facility in Singapore houses our R&D, product design and manufacturing operations under one roof. Its 15,000 sq. ft. clean room is fully equipped for enabling vertically integrated volume manufacturing, from wafer fabrication to test and packaging. We are ISO9001 certified in Singapore processing Indium Phosphide (InP) and Gallium Arsenide (GaAs) based opto-electronic devices and photonic integrated circuits through our in-house wafer fabrication and assembly & test facilities.

 

We have an experienced team with deep know-how in GaAs and InP semiconductors wafer processing and we continue to build on this technical base. Together with our operationally ready manufacturing and photonics design center, various ODM and design-in programs can be supported for both discrete and integrated optical components.

 

Interim MD&A Highlights

 

Revenue was $1,425,427 for the six months ended June 30, 2018 and gross margin was $837,310 or 59%. Reported revenue and gross margin for corresponding period in 2017 was $1,360,932 and $751,884, respectively or 55%. Our net loss from operations, before taxes for the period was $7,936,784 compared to a net loss from operations, before taxes of $6,491,907 for the corresponding period in 2017.

 

Significant Events and Milestones During the Six Months Ended June 30, 2018

 

In 2018, we continued to execute on our stated strategic plan. We achieved the following significant milestones during the first half of 2018:

 

1) On January 22, 2018, the Company appointed Don Listwin to the Board of Directors, replacing Todd DeBonis who served on the Board since April 2015. Listwin has over 30 years of technology investing and management experience, highlighted by a decade at Cisco Systems, where he served as executive vice president. During his tenure at Cisco, he built several multibillion-dollar lines of business, including the company’s Service Provider line of business that underpins much of today’s global Internet infrastructure. More recently, Listwin served as chief executive officer of both Sana Security and Openwave Systems.
     
2) On   January 29, 2018,   the   Company   announced the launch of its   Optical Interposer Platform, which facilitates the copackaging of electronics and optics in a single Multi-Chip Module (MCM). Based on its previously announced Dielectric Waveguide technology, POET’s Optical Interposer may provide the ability to run electrical and optical interconnections side-by-side on the same interposer chip at a micrometer scale. The Optical Interposer represents an integral part of POET’s hybrid integrated Optical Engine and leverages the manufacturing processes and unique capabilities of its dielectric waveguides.
  8  

 

3) On January 30, 2018, the Company successfully demonstrated a high frequency waveguide integrated PIN Photodiode targeting 100G and 400G data center applications. The PIN Photodetector successfully demonstrated a 3dB optical bandwidth of 37GHz, which is a typical requirement for achieving 50GBaud data rates. The achieved native bandwidths are more than capable of supporting the requirements of a 100G Receive Optical Engine (4 lanes at 25Gb/s each), and can be extended to support 200G/400G Optical Engines.
     
4) On March 5, 2018, the Company entered into a Memorandum of Understanding (MOU) for the co-development of products with Accelink Technologies Co., Ltd. (“Accelink”), a leading global supplier of optical components and subsystem products to the datacom, telecom and network access markets. As “Preferred Co-Development Partners” the MOU outlined a path for mutual cooperation with the objective of developing, qualifying and selling a family of transceiver products based on the Company’s low cost, high-performance Optical Interposer Platform. More specifically, the MOU is aimed at rapidly commercializing a series of advanced multichannel (100/400G) transmit and receive devices for the datacom markets and low-cost single channel (10/25G) products for telecom applications.
     
5) On March 21, 2018, the Company completed a brokered "bought deal" public offering of 25,090,700 units at a price of $0.425 (CAD$0.55) per unit for gross proceeds of $10,663,548 (CAD$13,799,885). Each unit consists of one common share and one-half common share purchase warrant. Each whole warrant entitles the holder to purchase one common share of the Company at a price of $0.58 (CAD$0.75) per share until March 21, 2020.
     
6) On March 28, 2018, the Company announced the appointment of Peter Charbonneau to its Board of Directors. Charbonneau was a general partner at Skypoint Capital Corporation for almost 15 years, where he was jointly responsible for the placement of $100 million of capital in early-stage telecommunications and data communication companies. Charbonneau currently serves on the board of directors at Mitel Networks, a leading global provider of cloud and on-site business communications and collaboration solutions, and Teradici Corporation, the creator of PCoIP protocol technology and Cloud Access Software. He previously served as Chairman of the Board of Trustees for the CBC Pension Board and a director on the board of the Canadian Broadcasting Corporation as well as many technology and networking companies, including March Networks Corporation, TELUS Corporation, Breconridge Corporation and Dragonwave Incorporated.
     
7) On April 9, 2018, the Company announced a master collaboration agreement with SilTerra, a Malaysia-based semiconductor wafer foundry, for the co-development of certain fabrication processes and the manufacturing of POET’s Optical Interposer Platform. The partnership is expected to accelerate the path to commercial production of the Optical Interposer, which will enable Optical Engines for single-mode transceiver modules and other high bandwidth devices.
     
8) On June 21, 2018, the Company announced the Company has executed an agreement for the co-development of transmit device solutions with Almae Technologies SAS (“Almae”), a France-based manufacturer of advanced photonic products. The purpose of the agreement is to jointly develop, manufacture and sell a series of laser modules based on the POET Optical Interposer platform into high-speed data communication applications. The companies will collaborate on designs of lasers and modulators to be compatible with POET’s Optical Interposer and to provide foundry services for both epitaxial supply and device fabrication.

 

  9  

 

Summary of Quarterly Results

 

Following are the highlights of financial data of the Company for the most recently completed eight quarters, which have been derived from the Company’s consolidated financial statements prepared in accordance with IFRS:

 

      Jun. 30/18     Mar. 28/18     Dec. 31/17     Sep. 30/17     Jun. 30/17     Mar. 31/17     Dec. 31/16     Sep. 30/16
Sales   $ 752,198     $ 673,229     $ 717,692     $ 715,420     $ 648,382     $ 712,550     $ 423,461     $ 861,545  
Cost of sales     319,939       268,178       385,456       348,187       320,857       288,191       346,462       318,976  
Research and development     1,899,564       1,638,209       1,661,887       1,078,934       1,186,042       1,147,003       1,104,733       581,354  
Depreciation and amortization     659,820       596,015       616,514       559,334       558,919       540,393       643,344       550,420  
Professional fees     188,560       197,766       203,372       98,101       167,726       155,742       96,009       207,220  
Wages and benefits     620,696       621,774       698,814       625,676       604,608       645,880       586,596       676,700  
Management and consulting fees     32,104       50,185       42,439       42,877       40,330       103,931       51,303       230,352  
Stock-based compensation (1)     1,063,773       792,122       1,032,158       1,088,170       159,783       894,813       903,253       1,019,970  
General expense, rent and facility     500,016       519,381       591,462       567,721       653,933       547,052       758,947       508,178  
Impairment and other loss     -       -       -       -       -       -       29,807       -  
Change in fair values     -       -       -       -       -       -       -       (283,130 )
Other (income), including interest     155,218       (761,109 )     (1,599,170 )     (4,990 )     (142,557 )     (19,807 )     (19,647 )     (11,473 )
Net loss before taxes   $ 4,687,492     $ 3,249,292     $ 2,915,240     $ 3,688,590     $ 2,901,259     $ 3,590,648     $ 4,077,346     $ 2,937,022  
 Net loss per share   $ (0.02 )   $ (0.01 )   $ (0.01 )   $ (0.01 )   $ (0.01 )   $ (0.01 )   $ (0.02 )   $ (0.01 )

 

(1) Stock based compensation allocated between General & Administrative and Research & Development issuances are combined for MD&A purposes. For financial statement presentation purposes, stock-based compensation is split between General & Administrative and Research & Development .

 

Explanation of Quarterly Results for the three months ended June 30, 2018 (“Q2 2018”) compared to the same three-month period in the prior year (“Q2 2017”)

 

Net loss before taxes for Q2 2018 was $4,687,492 compared to a net loss before taxes of $2,901,259 in Q2 2017, an increase of $1,786,233 or 62%. The following discusses the significant variances between Q2 2018 and Q2 2017.

 

During Q2 2018, the Company reported revenue of $752,198 through its DenseLight subsidiary compared to $648,382 in Q2 2017, a 16% increase. The increase in sales of $103,816 contributed to an increase in gross margin from 51% to 58%.

 

Research and development (“R&D”) increased by 60% or $713,522 to $1,899,564 in Q2 2018 from $1,186,042 in Q2 2017. Since the acquisition of DenseLight and BB Photonics in May and June of 2016 respectively, the Company has systematically increased its R&D activities in an effort to bring new products to market and expand its product portfolio. The increased R&D activity has contributed to the continued progress of the new POET Optical Interposer platform utilizing the Company’s proprietary dielectric waveguides. New skilled technical human resources, especially in optics and photonics device testing, represent the largest area of increase in R&D. The increase is consistent with the Company’s budgeted R&D activity.

 

  10  

 

Professional fees in Q2 2018 increased by 12% or $20,834 to $188,560 from $167,726 in Q2 2017. Professional fees, including legal fees were required as the Company reviewed internal policies for best practices and initiated co-development partnerships and agreements with certain counterparties during Q2 2018.

 

Non-cash stock-based compensation increased by 566% or $903,990 to $1,063,773 during Q2 2018 from $159,783 in Q2 2017. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors at the time of the grant consistent with the provisions of the Stock Option Plan, as amended (the “Plan”).

 

Non-cash depreciation and amortization increased by 18% or $100,901 to $659,820 in Q2 2018 to from $558,919 in Q2 2017. The Company has committed to improving its fabrication facilities in Singapore and its overall manufacturing capabilities, which includes acquiring new equipment for the Optical Interposer program. The addition of new equipment will result in increased depreciation charges.

 

Other (loss) income in Q2 2018 was a loss of $(155,218) as compared to income of $142,557 in Q2 2017. The Company is entitled to a recovery of certain qualifying expenses from the Economic Development Board (EDB) in Singapore. During the period, an audit of the Company’s claims was performed by a third party. The audit resulted in an approximate $150,000 reduction to the filed but unpaid claim as at June 30, 2018. Prior to Q4 2017 EDB recoveries were not accrued, as the Company did not have sufficient experience with the EDB process to confidently estimate the amounts to be recovered.

 

General administrative, rent and facility decreased by 24% or $153,917 from $653,953 in Q2 2017 to $500,016 in Q2 2018. The decrease is a function of lower repairs and maintenance cost to the facility.

 

Explanation of Results for the six months ended June 30, 2018 (the “period”) compared to the same six-month period in the prior year (“June 30, 2017”)

 

Net loss before taxes for the six-month period ended June 30, 2018 was $7,936,784 as compared to net loss before taxes of $6,491,907 for the six months ended June 30, 2017. The following explains 22% or $1,444,877 variance in net loss between June 30, 2018 and June 30, 2017.

 

Research and development (“R&D”) increased by 52% or $1,204,728 to $3,537,773 in 2018 from $2,333,045 in 2017. Since the acquisition of DenseLight and BB Photonics in May and June of 2016 respectively, the Company has systematically increased its R&D activities in an effort to bring new products to market and expand its product portfolio. The increased R&D activity has contributed to the continued progress of the new POET Optical Interposer platform utilizing the Company’s proprietary dielectric waveguides. As a result of increased R&D spending in the period, the Company successfully demonstrated the functionality of PIN photodetectors targeting 100G to 400G optical transceivers. New skilled technical human resources, especially in optics and photonics device testing, represent the largest area of increase in R&D. The increase is consistent with the Company’s budgeted R&D activity. Our expectation is that the R&D activity conducted in 2018 will lead to sales of new products in 2019.

 

Professional fees in the period increased by 19% or $62,858 to $386,326 from $323,468 in the same period of 2017. Professional fees increased over 2017 due to a mandatory requirement to conduct annual audits of EDB filings. No such audit was conducted in 2017. Additional professional fees, including legal fees were also required as the Company reviewed internal policies for best practices and initiated co-development partnerships and agreements with several counterparties as disclosed thus far in 2018.

 

  11  

 

Non-cash stock-based compensation increased by 76% or $801,299 to $1,855,895 during the period from $1,054,596 in 2017. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors at the time of the grant consistent with the provisions of the Stock Option Plan, as amended (the “Plan”).

 

Non-cash depreciation and amortization increased by 14% or $156,523 to $1,255,835 in the period from $1,099,312 in 2017. The Company has committed to improving its fabrication facilities in Singapore, and its overall manufacturing capabilities, which includes acquiring new equipment for the Optical Interposer program. The addition of new equipment will result in increased depreciation charges.

 

As a result of lower maintenance costs to equipment, the general expenses and rent category decreased by 15% or $181,588 in the period from $1,200,985 in 2017 to $1,019,397 in the 2018.

 

Other income in the period increased by $443,527 or 273% to $605,891 as compared to $162,364 in 2017. The Company is entitled to a recovery of certain qualifying expenses from the Economic Development Board (EDB) in Singapore. The increase is a result of a recoverable amount accrued during the Period to be received later in the year. Prior to Q4 2017 EDB recoveries were not accrued, as the Company did not have sufficient experience with the EDB process to confidently estimate the amounts to be recovered.

 

Explanation of Material Variations by Quarter for the Last Eight Quarters

 

Q2 2018 compared to Q1 2018

 

Net loss before taxes increased by $1,438,200 or 44% in Q1 2018 to $4,687,492 as compared to net loss before taxes of $3,249,292 in Q1 2018. The increased loss was driven primarily by the reduced EDB recovery, increased R&D, increased non-cash depreciation and amortization, and increased non-cash stock-based compensation.

 

Research and development (“R&D”) increased by 16% or $261,355 to $1,899,564 in Q2 2018 from $1,638,209 in Q1 2018. Since the acquisition of DenseLight and BB Photonics in May and June of 2016 respectively, the Company has systematically increased its R&D activities in an effort to bring new products to market and expand its product portfolio. The increased R&D activity has contributed to the continued progress of the new POET Optical Interposer platform utilizing the Company’s proprietary dielectric waveguides. New skilled technical human resources, especially in optics and photonics device testing, represent the largest area of increase in R&D. The increase is consistent with the Company’s budgeted R&D activity.

 

Non-cash stock-based compensation increased by 34% or $271,651 to $1,063,773 during Q2 2018 from $792,122 in Q1 2018. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors at the time of the grant consistent with the provisions of the Stock Option Plan, as amended (the “Plan”).

 

Non-cash depreciation and amortization increased by 11% or $63,805 to $659,820 in Q2 2018 to from $596,015 in Q1 2018. The Company has committed to improving its fabrication facilities in Singapore, and its overall manufacturing capabilities, which includes acquiring new equipment for the Optical Interposer program. The addition of new equipment will result in increased depreciation charges.

 

Other income (loss) reported in Q2 was ($155,218) as compared to $761,109 in Q1.  The majority of the loss is attributable to an adjustment in the amount of EDB recovery reported for Q1 of $761,109 resulting from an audit of the claim by a third-party.  The adjustment was made in Q2.  

 

  12  

 

Q1 2018 compared to Q4 2017

 

Net loss before taxes in Q1 2018 was $3,249,292 as compared to net loss before taxes of $2,915,240 in Q4 2017. The increased loss was driven primarily by the reduced EDB recovery. The EDB recovery reported in Q4 2017 was $1,599,170 which represented both amounts collected during that period and an amount accrued to be recovered in 2018. The accrued amount in Q4 2017 was a cumulative amount for most of the recoverable expenses incurred during the entire year of 2017 while the recoverable amount accrued in Q1 2018 was only for the expenses incurred up to March 31, 2018.

 

Expenses during Q1 2018 were lower than the expenses in Q4 2017. The largest difference was $240,036 relating to non-cash stock-based compensation which decreased by 23% from $1,032,158 in Q4 2017 to $792,122 in Q1 2018.

 

Wages and benefits decreased by $77,040 from $698,814 in Q4 2017 to $621,774 in Q1 2018. The Company paid an annual wage supplement in Q4 2017 to its employees in Singapore as part of an initiative to be a more competitive employer. Paying annual wage supplements, while not mandatory, are a standard employment practice in Singapore.

 

General expenses, rent and facility costs decreased by $72,081 from $591,462 in Q4 2017 to $519,381 in Q1 2018. The Company had no major instance of repairs and maintenance on equipment in its fabrication facility in Q1 2018 as had occurred in Q4 2017, and as a result, the rent and facility costs were lower in Q1 2018 as compared to Q4 2017.

 

Q4 2017 compared to Q3 2017

 

R&D increased by 54% or $582,953 to $1,661,887 in Q4 2017 from $1,078,934 in Q3 2017. Head count and recruitment costs were the largest contributing factors to the period over period increase. As a result of increased R&D spending in Q4 2017, the Company announced the development of its new POET Optical Interposer platform and demonstrated the functionality of PIN photodetectors targeting 100G to 400G optical transceivers. Skilled technical human resource represents the largest area of increase in R&D.

 

Professional fees in Q4 2017 increased by 107% or $105,271 to $203,372 from $98,101 in Q3 2017. Additional professional fees, including legal fees were also required as the Company reviewed internal policies for best practices and initiated co-development partnerships and agreements with several counterparties as disclosed in early 2018.

 

Wages and benefits increased by 12% or $73,138 from $625,676 in Q3 2017 to $698,814 in Q4 2017. The increase is a result of the new employees and other payroll related obligations as the Company ramped its technical resource and production-related capabilities.

 

Other income in Q4 2017 was $1,599,170 as compared to $4,990 in Q3 2017. The Company is entitled to a recovery of certain qualifying expenses from EDB in Singapore. The increase is a result of both collected recoveries and an amount accrued in 2017 to be received in 2018. Prior to Q4 2017 EDB recoveries were not accrued, as the Company did not have sufficient experience with the EDB process to confidently estimate the amounts to be recovered.

 

Q3 2017 compared to Q2 2017

 

Sales were $67,038 higher to $715,420 in Q3 2017 from $648,382 Q2 2017. The increase is a function of shipping more units in Q3 2017 than in Q2 2017.

 

  13  

 

Professional fees decreased by 42% or $69,625 to $98,101 in Q3 2017 from $167,726 in Q2 2017. The Company had less professional service activity in Q3 2017 than in Q2 2017, including lower recruitment fees, legal and audit-related expenses.

 

Non-cash stock-based compensation increased by $928,387 or 581% to $1,088,170 in Q3 2017 from $159,783 in Q2 2017. The departure of employees and consultants who had unvested stock options contributed to the unusually low expense in Q2 2017. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company’s stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors at the time of the grant consistent with the provisions of the Stock Option Plan, as amended (the “Plan”).

 

General expenses, rent and facility decreased by $86,212 or 13% to $567,721 in Q3 2017 from $653,933 in Q2 2017. In Q2 2017, the Company had significant facility and factory maintenance costs. While the company continues to have facility and factory maintenance costs on a period over period basis, the expense was lower in Q3 2017 than Q2 2017.

 

Q2 2017 compared to Q1 2017

 

Gross margin was 51% in Q2 2017 as compared to 60% in Q1 2017. The reduced gross margin was a result of lower absorption of factory costs from reduced revenue of $648,382 in Q2 2017 compared to $712,550 in Q1 2017. Cost of sales includes certain fixed costs that do not change in a linear fashion with revenue.

 

Management and consulting fees decreased by $63,601 or 61% to $40,330 in Q2 2017 from $103,931 in Q1 2017. The resignation of Mr. Manocha as Executive Chairman of the Board contributed to this the decrease.

 

Non-cash stock-based compensation decreased by $735,030 or 82% to $159,783 in Q2 2017 from $894,813 in Q1 2017. The departure of employees and consultants who had unvested stock options contributed to the substantial reduction from Q1 2017.

 

General expenses, rent and facility increased by $106,881 or 20% to $653,933 in Q2 2017 from $547,052 in Q1 2017. In Q2 2017, the Company had additional facility and factory maintenance.

 

Q1 2017 compared to Q4 2016

 

Sales in Q1 2017 were $712,550 as compared to $423,461 in Q4 2016. Backlog from 2016 contributed to increased Q1 sales, along with $80,000 of NRE revenue. Gross margin percent for the quarter was 60% compared to the 18% in Q4 2016.

 

R&D increased by $42,270 or 4% to $1,147,003 in Q1 2017 from $1,104,733 in Q4 2016. Development costs of $272,000, which were capitalized in prior periods, were expensed to R&D in Q4 2016 as the Company no longer felt those capitalized costs continued to meet the criteria for capitalization. The Company did not expense any capitalized R&D costs in Q1 2017.

 

Professional fees increased by $59,733 or 62% to $155,742 in Q1 2017 from $96,009 in Q4 2016. Professional fees relating the Company’s year-end audit contributed to the quarter over quarter increase.

 

Wages and benefits increased by 10% or $59,284 to $645,880 Q1 2017 from $586,596 in Q4 2016. Wages and benefits were lower in Q4 2016 due to the reversal of an accrued and unpaid retention bonus of $100,000 to the former COO in Q1 2017. Additionally, Q1 2017 wages and benefits included the wages of the new CFO, the new President of DenseLight, the new VP of Sales for the Asia-Pacific region and the new Executive Chairman of the Board.

 

General expenses, rent and facility decreased by $211,895 or 28% to $547,052 in Q1 2017 from $758,947 in Q4 2016. General expenses were higher in Q4 2016 due to the ancillary costs such as travel, and other administrative costs associated with the $9.3 million equity financing in Q4 2016.

 

  14  

 

Management and consulting fees increased by $52,628 or 103% to $103,931 in Q1 2017 from $51,303 in Q4 2016. A reclassification of $75,000 of consulting fees paid to a director in Q4 2016 from management and consulting to the cost of financing resulted in the lower expense in this category in Q4 2016.

 

Q4 2016 compared to Q3 2016

 

Sales in Q4 2016 were $423,461 compared to $861,545 in Q3 2016. The reduction in Q4 sales was a result of backlog pushed into Q1 2017 resulting from production challenges with one large customer. Expected Q4 NRE was also delayed and was not recognized until Q1 2017.

 

R&D expenses increased by $523,379 or 90% to $1,104,733 in Q4 2016 compared to $581,534 in Q3 2016. Development costs of $272,000, which were capitalized in prior periods, were expensed to R&D in Q4 2016 as the Company no longer felt those capitalized costs continued to meet the criteria for capitalization. Q3 2016 R&D was also limited in scope because of certain export restrictions. Those restrictions were resolved, resulting in the Company incurring costs in Q4 2016 that would have been incurred more evenly throughout the year.

 

Q4 2016 professional fees were $96,009 compared to $207,220 in Q3 2016. The quarter over quarter reduction of $111,211 or 54% was a result of the Company settling most issues in Q3 and earlier periods relating to corporate acquisitions, financing and the export issues that required professional advisors.

 

Wages and benefits were $586,596 in Q4 2016 and $676,700 in Q3 2016. The reduction of $90,104 or 13% was from cost savings resulting from the 10-20% temporary non-recoverable reduction in US management compensation, a recovery of an accrued but unpaid retention bonus of $100,000 to the former COO, and staff reductions at DenseLight.

 

The reduction in management and consulting fees of $179,049 or 78% to $51,303 in Q4 2016 from $230,352 in Q3 2016 was a result of a 10% to 20% reduction in management fees to head-office-based executives, along with a reclassification of $75,000 of consulting fees paid to a director in Q3 2016. The fees were paid in Q3 2016 and classified as general consulting fees but were reclassified to financing cost in Q4 2016.

 

General expenses, rent and facility increased by $250,769 or 49% to $758,947 in Q4 2016 from $508,178 in Q3 2016. The increase included ancillary costs such as travel and other administrative costs related to the $9.3M financing that were not included as finance costs.

 

Segment Disclosure

 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semi-conductor products and services for commercial applications. The Company’s operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:

 

ODIS Inc. (“ODIS”)

 

ODIS is the developer of the POET platform semiconductor process IP for fabrication of integrated circuit devices containing both electronic and optical elements on a single die ("monolithic integration") and in a single package ("hybrid integration").

 

 

  15  

 

BB Photonics

 

BB Photonics develops photonic integrated components for the datacenter market utilizing embedded dielectric technology that is intended to enable on-chip athermal wavelength control and lower the total solution cost of datacenter photonic integrated circuits.

 

DenseLight

 

DenseLight designs, manufactures, and delivers photonic optical light source products and solutions to the communications, medical, instrumentations, industrial, defense, and security industries. DenseLight processes compound semiconductor-based optoelectronic devices and photonic integrated circuits through its in-house wafer fabrication and assembly & test facilities. The Company operates geographically in the United States, Canada and Singapore. Geographical information is as follows:

 

 

    2018
As of June 30,   Singapore   US   Canada   Consolidated
Current assets   $ 2,569,804     $ 1,569,108     $ 8,362,125     $ 12,501,037  
Property and equipment     8,917,426       222,819       -       9,140,245  
Patents and licenses     18,196       422,924       -       441,120  
Goodwill and intangibles assets     6,737,567       1,764,459       -       8,502,026  
Total Assets   $ 18,242,993     $ 3,979,310     $ 8,362,125     $ 30,584,428  

 

For the Six Months Ended June 30,   Singapore   US   Canada   Consolidated
Sales   $ (1,425,427 )   $ -     $ -     $ (1,425,427 )
Cost of sales     588,117       -       -       588,117  
Selling, marketing and administration     2,517,806       2,571,098       494,589       5,583,493  
Research and development     1,676,887       1,914,047       205,558       3,796,492  
Other income including Investment income     (605,891 )     -       -       (605,891 )
Net loss from operations   $ 2,751,492     $ 4,485,145     $ 700,147     $ 7,936,784  

 

    2017
As of December 31,   Singapore   US   Canada   Consolidated
Current assets   $ 3,190,298     $ 4,621,318     $ 139,096     $ 7,950,712  
Property and equipment     8,018,900       259,270       -       8,278,170  
Patents and licenses     18,816       437,434       -       456,250  
Goodwill and intangible assets     6,756,181       1,764,459       -       8,520,640  
Total Assets   $ 17,984,195     $ 7,082,481     $ 139,096     $ 25,205,772  

 

For the Six Months Ended June 30,   Singapore   US   Canada   Consolidated
Sales   $ (1,360,932 )   $ -     $ -     $ (1,360,932 )
Cost of sales     609,048       -       -       609,048  
General and administration     1,464,967       3,047,999       410,511       4,923,477  
Research and development     1,119,598       1,251,517       111,563       2,482,678  
Other income     (145,044 )     (2,395 )     (14,925 )     (162,364 )
Net loss from operations   $ 1,687,637     $ 4,297,121     $ 507,149     $ 6,491,907  

 

 

  16  

 

Liquidity and Capital Resources

 

The Company had working capital of $10,591,896 on June 30, 2018 as compared to $7,140,119 on December 31, 2017.

 

The Company’s balance sheet as of June 30, 2018 reflects assets with a book value of $30,584,428 compared to $25,205,772 as of December 31, 2017. Forty-one percent (41%) of the book value as of June 30, 2018, or $12,501,037, was in current assets consisting primarily of cash and other current assets, compared to thirty-two percent (32%), or $7,950,712 as of December 31, 2017.

 

On March 21, 2018, the Company strengthened its working capital position relative to December 31, 2017 by completing a “bought deal” public offering of 25,090,700 units at a price of $0.425 (CAD$0.55) per unit for gross proceeds of $10,663,548 (CAD$13,799,885). Each unit consists of one common share and one-half common share purchase warrant. Each whole warrant entitles the holder to purchase one common share of the Company at a price of $0.58 (CAD$0.75) per share until March 21, 2020. The broker was paid a cash commission of $639,813 (6%) of the gross proceeds and received 1,505,442 compensation options. Each compensation option is exercisable into one compensation unit of the Company at a price of $0.425 (CAD$0.55) per compensation unit until March 21, 2020 with each compensation unit comprising one common share and one-half compensation share purchase warrant. Each whole compensation share purchase warrant entitles the broker to purchase one common share of the Company at a price of $0.425 (CAD$0.55) per share until March 21, 2020. The Company paid or accrued an additional $553,331 in other costs related to this financing. The Company received $9,470,404 net of share issue costs. Additionally, the Company raised $1,110,746 from the exercise of warrants and stock options.

 

Related Party Transactions

 

Compensation to key management personnel (Executive Chairman, CEO, CFO, and President and General Manager of DenseLight) was as follows for the six months ended June 30:

 

    2018   2017
         
Salaries   $ 546,667     $ 487,133  
Share-based payments (1)     1,200,217       1,280,798  
Total   $ 1,746,884     $ 1,767,931  

 

(1) Share-based payments are the fair value of options granted to key management personnel and expensed during the various years as calculated using the Black-Scholes model.

 

The Company paid or accrued $29,379 and $59,045 in fees for the three and six months ended June 30, 2018 (2017 - $28,313 and $55,556) to a law firm, of which a director (John O’Donnell) is counsel, for legal services rendered to the Company.

 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

 

  17  

 

Critical Accounting Estimates

 

Accounts receivable

 

Accounts receivable are amounts due from customers from the sale of products or services in the ordinary course of business. Accounts receivables are classified as current (on the consolidated statements of financial position) if payment is due within one year of the reporting period date and are initially recognized at fair value and subsequently measured at amortized cost.

 

The provision policy for doubtful accounts of the Company is based on the ageing analysis and management's ongoing evaluation of the recoverability of the outstanding receivables. A considerable amount of judgment is required in assessing the ultimate realization of these receivables, including the assessment of the creditworthiness and the past collection history of each customer. If the financial conditions of these customers were to deteriorate , resulting in an impairment of their ability to make payments, additional allowances may be required. As at the balance sheet date, no provision was required for accounts receivable.

 

Inventory

 

Inventory consists of raw material inventory, work in process, and finished goods and are recorded at the lower of cost and net realizable value. Cost is determined on a first in first out basis and includes all costs of purchase, costs of conversion and other costs incurred in bringing the inventory to its present condition.

 

An assessment is made of the net realizable value of inventory at each reporting period. Net realizable value is the estimated selling price less the estimated cost of completion and the estimated costs necessary to make the sale. When circumstances that previously caused inventory to be written down no longer exist or when there is clear evidence of an increase in net realizable value because of changed economic circumstances, the amount of any write down previously recorded is reversed so that the new carrying amount is the lower of the cost and the revised net realizable value. Raw materials are not written down unless the goods in which they are incorporated are expected to be sold for less than cost, in which case, they are written down by reference to replacement cost of the raw materials, as this is the best indicator of net realizable value.

 

Property and equipment

 

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

 

Machinery and equipment   Straight Line, 5 years
     
Leasehold improvements   Straight Line, 5 years or life of the lease, whichever is less
     
Office equipment   Straight Line, 3 - 5 years

 

Patents and licenses

 

Patents and licenses are recorded at cost and amortized on a straight-line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

 

Intangible assets

 

Internally generated intangible assets are recorded at cost and will be amortized on a straight-line basis based on the best estimate of the useful life of the asset developed from the point at which the asset is ready for use. Internally generated intangible assets are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable. Externally acquired intangible assets are amortized on a straight-line basis over 5 years commencing when the asset is ready for use. Externally generated intangible assets are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable.

 

  18  

 

Stock-based Compensation

 

Stock options and warrants awarded to non-employees are accounted for using the fair value of the instrument awarded or service provided, whichever is considered more reliable. Stock options and warrants awarded to employees are accounted for using the fair value method. The fair value of such stock options and warrants granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option-pricing model with assumptions applicable at the date of grant.

 

Other stock-based payments

 

The Company accounts for other stock-based payments based on the fair value of the equity instruments issued or service provided, whichever is more reliable.

 

Cumulative Translation Adjustment

 

IFRS requires certain gains and losses such as certain exchange gains and losses arising from the translation of the financial statements of a self-sustaining foreign operation to be included in comprehensive income.

 

Recent Accounting Pronouncements

 

The Company has considered all recently issued accounting pronouncements and does not believe the adopting of such pronouncements will have a material impact on its consolidated financial statements. Please see note 3 of the financial statements for additional information.

 

Financial Instruments and Risk Management

 

The Company's financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that the fair value of these instruments approximates fair value due to their short-term nature.

 

Exchange Rate Risk

 

The Company is exposed to foreign currency risk with the Canadian dollar and Singapore dollar due to cash reserves and other current assets and liabilities that are maintained in those currencies, all of which are exposed to currency fluctuations. Most of the Company’s operations are transacted in US dollars and Singapore Dollars. A 10% change in the Canadian dollar and Singapore dollar would increase or decrease other comprehensive loss by $914,100.

 

Interest Rate Risk

 

Cash equivalents bear interest at fixed rates, and as such, are subject to interest rate risk resulting from changes in fair value from market fluctuations in interest rates. The Company does not depend on interest from its investments to fund its operations.

 

Credit Risk

 

The Company is exposed to credit risk associated with its accounts receivable. The Company has accounts receivable from both governmental and non-governmental agencies. Credit risk is minimized substantially by ensuring the credit worthiness of the entities with which it carries on business. Credit terms are provided on a case-by-case basis. The Company has not experienced any significant instances of non-payment from its customers. No provision has been made for potentially uncollectable amounts .

 

 

  19  

 

The Company's accounts receivable ageing was as follows:

 

    June 30,   December 31,
    2018   2017
Current   $ 349,831     $ 330,731  
31 - 60 days     9,976       56,094  
61 - 90 days     -       -  
> 90 days     73,801       107,100  
    $ 433,608     $ 493,925  

 

World Economic Risk

 

Like many other companies, the world economic climate could have an impact on the Company's business and the business of many of its current and prospective customers. A slump in demand for electronic-based devices, due to a world economic crisis, may impact any anticipated licensing revenue.

 

Obsolescence Risk

 

The Company designs, manufactures and sells various highly technological electronic products that could become obsolete should lower priced competitors or new technology enter the market. This would expose the company to obsolescence risk in inventory balances, but also a risk of obsolescence in the product offering. The redesign of the product offering could take significant time or could never occur.

 

Liquidity Risk

 

The Company predominately relies on equity funding for liquidity to meet current and foreseeable financial requirements.

 

Strategy and Outlook

 

There are a number of projects that the Company expects will address the short-term and long-term growth plans of the Company including, but not limited to the following:

 

· Introduce the Optical Interposer concept to suppliers of transceivers and data center operators and form commercial partnerships for product development;

 

· Promote the POET Optical Interposer as a true platform technology across several photonic applications and markets ;

 

· Pursue multiple potential sources of non-product revenue and strategic partnerships;

 

· Continue to invest in our capabilities and infrastructure;

 

· Selectively pursue other opportunities that leverage our existing expertise; and

 

· Pursue complementary strategic alliance or acquisition opportunities .

 

Outstanding Share Data

 

Common Shares

 

Total common shares of the Company outstanding at June 30, 2018 and August 15, 2018 were 288,057,303.

 

  20  

 

Stock Options, Warrants and Compensation Options

 

Total warrants outstanding to purchase common shares of the Company at June 30, 2018 and August 15, 2018 were 44,744,850 priced between CA$0.52 and CA$0.75 per common share.

 

Total compensation units due to brokers as at June 30, 2018 and August 15, 2018 were 1,505,442, priced at CA$0.55. Each compensation unit is convertible into one common share and one half common share purchase warrant.

 

Total stock options outstanding as at June 30, 2018 and August 15, 2018 were 42,298,729, priced between CA$0.20 and CA$1.99 per common share.

 

Additional detailed share data information is available in the Company’s Notes to Consolidated Financial Statement.

 

Off-Balance Sheet Arrangements

 

The Company has not entered into any off-balance sheet arrangements.

 

Key Business Risks and Uncertainties

 

The process of developing new, technologically advanced products in semiconductor manufacturing and photonics products is highly complex and uncertain, and we cannot guarantee a positive result.

 

The development of new, technologically advanced products is a complex and uncertain process requiring frequent innovation, highly-skilled engineering and development personnel and significant capital, as well as the accurate anticipation of technological and market trends. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully or on a timely basis. Further, we cannot assure you that our new products will gain market acceptance or that we will be able to respond effectively to product introductions by competitors, technological changes or emerging industry standards. We also may not be able to develop the underlying core technologies necessary to create new products and enhancements, license these technologies from third parties, or remain competitive in our markets.

 

Customer demand is difficult to forecast accurately and, as a result, we may be unable to match production with customer demand.

 

We make planning and spending decisions, including determining the levels of business that we will seek and accept, production schedules, component procurement commitments, personnel needs and other resource requirements, based on our estimates of product demand and customer requirements. Our products are typically sold pursuant to individual purchase orders. While our customers may provide us with their demand forecasts, they are typically not contractually committed to buy any quantity of products beyond firm purchase orders. Furthermore, many of our customers may increase, decrease, cancel or delay purchase orders already in place without significant penalty. The short-term nature of commitments by our customers and the possibility of unexpected changes in demand for their products reduce our ability to accurately estimate future customer requirements. If any of our customers decrease, stop or delay purchasing our products for any reason, we will likely have excess manufacturing capacity or inventory and our business and results of operations would be harmed.  

 

If our customers do not qualify our products for use on a timely basis, our results of operations may suffer. 

 

Prior to the sale of new products, our customers typically require us to “qualify” our products for use in their applications. At the successful completion of this qualification process, we refer to the resulting sales opportunity as a “design win.” Additionally, new customers often audit our manufacturing facilities and perform other evaluations during this qualification process. The qualification process involves product sampling and reliability testing and collaboration with our product management and engineering teams in the design and manufacturing stages. If we are unable to accurately predict the amount of time required to qualify our products with customers, or are unable to qualify our products with certain customers at all, then our ability to generate revenue could be delayed or our revenue would be lower than expected and we may not be able to recover the costs associated with the qualification process or with our product development efforts, which would have an adverse effect on our results of operations.

 

  21  

 

The markets in which we operate are highly competitive, which could result in lost sales and lower revenues.

 

The market for optical components and modules is highly competitive and this competition could result in our existing customers moving their orders to our competitors. We are aware of a number of companies that have developed or are developing optical component products, including LEDs, lasers, pluggable components, modules and subsystems, photonic integrated circuits, among others, that compete directly with our current and proposed product offerings.

 

Some of our current competitors, as well as some of our potential competitors, have longer operating histories, greater name recognition, broader customer relationships and industry alliances and substantially greater financial, technical and marketing resources than we do. We may not be able to compete successfully with our competitors and aggressive competition in the market may result in lower prices for our products and/or decreased gross margins. Any such development could have a material adverse effect on our business, financial condition and results of operations.

 

Our products, including those sold by predecessor company, OPEL Solar, could contain defects that may cause us to incur significant costs or result in a loss of customers or subject us to claims for which we may not be fully insured.

 

Our predecessor company, Opel Solar, sold solar systems and products between 2007 and 2012, and some of those products may still be under warranty. We have not undertaken to quantify the size of that warranty obligation and it is not recorded on our balance sheet because it is not determinable. Although we carry product liability insurance, this insurance may not adequately cover our costs arising from defects or warranty claims related to those products.

 

Our current products sold by DenseLight are complex and undergo quality testing as well as formal qualification by our customers. Our customers’ testing procedures are limited to evaluating our products under likely and foreseeable failure scenarios and over varying amounts of time. For various reasons, such as the occurrence of performance problems that are unforeseeable in testing or that are detected only when products age or are operated under peak stress conditions, our products may fail to perform as expected long after customer acceptance. Failures could result from faulty components or design, problems in manufacturing or other unforeseen reasons. As a result, we could incur significant costs to repair or replace defective products under warranty, particularly when such failures occur in installed systems. Our products are typically embedded in, or deployed in conjunction with, our customers’ products, which incorporate a variety of components, modules and subsystems and may be expected to interoperate with modules produced by third parties. As a result, not all defects are immediately detectable and when problems occur, it may be difficult to identify the source of the problem. We will continue to face this risk going forward because our products are widely deployed in many demanding environments and applications worldwide. In addition, we may in certain circumstances honor warranty claims after the warranty has expired or for problems not covered by warranty to maintain customer relationships. Any significant product failure could result in litigation, damages, repair costs and lost future sales of the affected product and other products, divert the attention of our engineering personnel from our product development efforts and cause significant customer relations problems, all of which would harm our business. Although we carry product liability insurance, this insurance may not adequately cover our costs arising from defects in our products or otherwise.

 

  22  

 

The business that we acquired did not have a history of profitable operations. Our ability to successfully manage our manufacturing operations is essential to our overall success, and if we fail to do so, our financial results will suffer.

 

At the time of the acquisition of DenseLight Semiconductors, Pte. Ltd. in May of 2016, the company had been operating at a loss for several years and was at a minimum staffing level. Since the acquisition, we have committed substantial capital and management attention to improving the operation, increasing sales and driving to profitability. Even though substantial changes in the management and personnel have been made, the results to date have been less than anticipated and more improvement will be required in order to make the DenseLight operation profitable. We cannot guarantee that our efforts to improve the DenseLight operation will be successful, and if they are not, the operation will continue to need capital and attention from the senior management of the company and our financial results may suffer as a result.

 

If we encounter manufacturing problems or if manufacturing at our Singapore operation is discontinued for any reason, including an industrial or workplace accident, we may lose sales and damage our customer relationships, or be subject to claims for which we may not be fully insured.

 

We may experience delays, disruptions or quality control problems in our manufacturing operations. These and other factors may cause less than acceptable yields at our wafer fabrication facility. Manufacturing yields depend on a number of factors, including the quality of available raw materials, the degradation or change in equipment calibration and the rate and timing of the introduction of new products. Changes in manufacturing processes required as a result of changes in product specifications, changing customer needs and the introduction of new products may significantly reduce our manufacturing yields, resulting in low or negative margins on those products. In addition, because of our wafer size, we use equipment that is not readily available on the open market and for which spare parts and qualified service people may not be available. If any of our key equipment were to be damaged or destroyed for any reason, our manufacturing process would be severely disrupted. Any such manufacturing problems would likely delay product shipments to our customers, which would negatively affect our sales, competitive position and reputation.

 

Our operations in Singapore are subject to government regulations that protect the workplace safety of employees. We strive to maintain an accident-free workplace, but we cannot guarantee that industrial accidents will not take place, or that we will not be subject to liability for these and other workplace related claims. We have obtained insurance policies to protect the company against claims for workplace related claims, but we cannot guarantee that these and other insurance policies carried by the Company will be sufficient to cover the full costs of such claims, which could have a material adverse effect on the Company.

 

We have limited operating history in the datacom market, and our business could be harmed if this market does not develop as we expect.

 

The initial target market for our Optical Interposer-based optical engine is the datacom market and we have no experience in selling products in this market. We may not be successful in developing a product for this market and even if we do, it may never gain widespread acceptance by large data center operators. If our expectations for the growth of the datacom market are not realized, our financial condition or results of operations may be adversely affected.

 

We depend on a limited number of suppliers and key contract manufacturers who could disrupt our business and technology development activities if they stopped, decreased, delayed or were unable to meet our demand for shipments of their products or manufacturing of our products.

 

We depend on a limited number of suppliers of epitaxial wafers and contract manufacturers for both our Indium Phosphide (“InP”) and our Gallium Arsenide (“GaAs”) development and production activities. Some of these suppliers are sole source suppliers. We typically have not entered into long-term agreements with our suppliers. As a result, these suppliers generally may stop supplying us materials and other components at any time. Our reliance on a sole supplier or limited number of suppliers could result in delivery problems, reduced control over technology development, product development, pricing and quality, and an inability to identify and qualify another supplier in a timely manner. Some of our suppliers that may be small or under-capitalized may experience financial difficulties that could prevent them from supplying us materials and other components. In addition, our suppliers, including our sole source suppliers, may experience manufacturing delays or shut downs due to circumstances beyond their control such as earthquakes, floods, fires, labor unrest, political unrest or other natural disasters. A Change in supplier could require technology transfer that could require multiple iterations of test wafers. This could result in significant delays in resumption of production.

 

  23  

 

Any supply deficiencies relating to the quality or quantities of materials or equipment we use to manufacture our products could materially and adversely affect our ability to fulfill customer orders and our results of operations. Lead times for the purchase of certain materials and equipment from suppliers have increased and, in some cases, have limited our ability to rapidly respond to increased demand, and may continue to do so in the future. To the extent we introduce additional contract manufacturing partners, introduce new products with new partners and/or move existing internal or external production lines to new partners, we could experience supply disruptions during the transition process. In addition, due to our customers’ requirements relating to the qualification of our suppliers and contract manufacturing facilities and operations, we cannot quickly enter into alternative supplier relationships, which prevent us from being able to respond immediately to adverse events affecting our suppliers.

 

Our international business and operations expose us to additional risks.

 

Products shipped to customers located outside Canada and the United States account for a majority of our revenues. In addition, we have significant tangible assets located outside the United States, including manufacturing facilities which are located in Singapore. Conducting business outside Canada and the United States subjects us to a number of additional risks and challenges, including:

 

periodic changes in a specific country's or region's economic conditions, such as recession;
     
licenses and other trade barriers;
     
the provision of services may require export licenses;
     
environmental regulations;
     
certification requirements;
     
fluctuations in foreign currency exchange rates;
     
inadequate protection of intellectual property rights in some countries;
     
preferences of certain customers for locally produced products;
     
potential political, legal and economic instability, foreign conflicts, and the impact of regional and global infectious illnesses in the countries in which we and our customers, suppliers and contract manufacturers are located;
     
Canadian and U. S. and foreign anticorruption laws;
     
seasonal reductions in business activities in certain countries or regions; and
     
fluctuations in freight rates and transportation disruptions.

 

  24  

 

These factors, individually or in combination, could impair our ability to effectively operate one or more of our foreign facilities or deliver our products, result in unexpected and material expenses, or cause an unexpected decline in the demand for our products in certain countries or regions. Our failure to manage the risks and challenges associated with our international business and operations could have a material adverse effect on our business.

 

If we fail to attract and retain key personnel, our business could suffer.

 

Our future success depends, in part, on our ability to attract and retain key personnel, including executive management. Competition for highly skilled technical personnel is extremely intense and we may face difficulty identifying and hiring qualified engineers in many areas of our business. We may not be able to hire and retain such personnel at compensation levels consistent with our existing compensation and salary structure. Our future success also depends on the continued contributions of our executive management team and other key management and technical personnel, each of whom would be difficult to replace. The loss of services of these or other executive officers or key personnel or the inability to continue to attract qualified personnel could have a material adverse effect on our business.

 

Our prior acquisitions created a large amount of goodwill, which may become impaired in the future and as a result may adversely affect our financial results. In addition, past and any future acquisitions may adversely affect our financial condition and results of operations.

 

As part of our business strategy, we have in the past and may in the future pursue acquisitions of companies that we believe could enhance or complement our current product portfolio, augment our technology roadmap or diversify our revenue base. Acquisitions involve numerous risks, any of which could harm our business, including: 

 

difficulties integrating the acquired business;
     
unanticipated costs, capital expenditures, liabilities or changes to product development efforts;
     
difficulties integrating the business relationships with suppliers and customers of the acquired business with our existing operations;
     
acts or omissions by the acquired company prior to the acquisition that may subject us to unknown risks or liabilities;
     
risks associated with entering markets in which we have little or no prior experience;
     
potential loss of key employees, particularly those of the acquired organizations; and 
     
diversion of financial and management resources from our existing business;

 

Our prior acquisitions have resulted, and future acquisitions may result in the recording of goodwill and other intangible assets subject to potential impairment in the future, adversely affecting our operating results. We may not achieve the anticipated benefits of an acquisition if we fail to evaluate it properly, and we may incur costs in excess of what we anticipate. A failure to evaluate and execute an acquisition appropriately or otherwise adequately address these risks may adversely affect our financial condition and results of operations. 

 

  25  

 

Our predecessor company received and our current subsidiaries receive and expect to receive in the future subsidies and other types of funding from government agencies in the locations in which we operate. The funding agreements stipulate that if we do not comply with various covenants, including eligibility requirements, and/or do not achieve certain pre-defined objectives, those government agencies may reclaim all or a portion of the funding provided. If this were to occur, we would either not be in a position to repay the claimed amounts or could have to borrow large sums, which would adversely affect our financial condition.

 

Our subsidiary ODIS received research and development grants from the United States Air Force and from NASA; our recently acquired subsidiary, DenseLight Semiconductor, Pte, Ltd. receives funding for new product development activities conducted in Singapore from the Economic Development Board; and we expect that our recently acquired subsidiary BB Photonics UK. Ltd., may also apply for certain grants to defer the cost of development in the U.K. The rules for eligibility vary widely across government agencies, are complex and may be subject to different interpretations. Furthermore, some of the grants set pre-defined development or spending objectives, which we may not achieve. We cannot guarantee that one or more agencies will not seek repayment of all or a portion of the funds provided, and if this were to occur, we would have to borrow large sums or otherwise raise the necessary funds (assuming we would even be able to do so), in order to make the repayments, which would adversely affect our financial.

 

We may be subject to disruptions or failures in information technology systems and network infrastructures that could have a material adverse effect on our business and financial condition.

 

We rely on the efficient and uninterrupted operation of complex information technology systems and network infrastructures to operate our business. A disruption, infiltration or failure of our information technology systems as a result of software or hardware malfunctions, system implementations or upgrades, computer viruses, third-party security breaches, employee error, theft or misuse, malfeasance, power disruptions, natural disasters or accidents could cause a breach of data security, loss of intellectual property and critical data and the release and misappropriation of sensitive competitive information and partner, customer, and employee personal data. Any of these events could harm our competitive position, result in a loss of customer confidence, cause us to incur significant costs to remedy any damages and ultimately materially adversely affect our business and financial condition.

 

We have a history of large operating losses. We may not be able to achieve or sustain profitability in the future and as a result we may not be able to maintain sufficient levels of liquidity.

 

We have historically incurred losses and negative cash flows from operations since our inception. As of June 30, 2018, we had an accumulated deficit of $124,660,967. For the years ended December 31, 2017 and December 31, 2016, we incurred net losses before income taxes of $13,095,737 and $13,431,941 respectively. The loss before income taxes for the six months ended June 30, 2018 was $7,936,784.

 

As of June 30, 2018, we held $9,991,005 in cash, and we had working capital of $10,591,896.

 

The Company is currently in a position to cover its liabilities as they come due. However, we have sustained considerable operating losses in the past.  Should such losses continue, the Company may need to seek debt or equity financing to fund its operations. Although the Company has been successful in obtaining such financings in the past, there is no assurance that it will be able do so in the future. If the Company is unable to obtain such financing, it may have an adverse effect on the Company’s ability to continue operations. Consistent with its needs for additional financing, on March 21, 2018, the Company completed a “bought deal” public offering of 25,090,700 units at a price of $0.425 (CAD$0.55) per unit for gross proceeds of $10,663,548 (CAD$13,799,885). Additionally, the Company raised $1,110,544 from the exercise of warrants and stock options.

 

The optical data communications industry is subject to significant operational fluctuations. In order to remain competitive, we incur substantial costs associated with research and development, qualification, production capacity and sales and marketing activities in connection with products that may be purchased, if at all, long after we have incurred such costs. In addition, the rapidly changing industry in which we operate, the length of time between developing and introducing a product to market, frequent changing customer specifications for products, customer cancellations of products and general down cycles in the industry, among other things, make our prospects difficult to evaluate. As a result of these factors, it is possible that we may not (i) generate sufficient positive cash flow from operations; (ii) raise funds through the issuance of equity, equity-linked or convertible debt securities; or (iii) otherwise have sufficient capital resources to meet our future capital or liquidity needs. There are no guarantees we will be able to generate additional financial resources beyond our existing balances.

 

  26  

 

We may not be able to obtain additional capital when desired, on favorable terms or at all.

 

We operate in a market that makes our prospects difficult to evaluate and, to remain competitive, we will be required to make continued investments in capital equipment, facilities and technology. We expect that substantial capital will be required to continue technology and product development, to expand our manufacturing capacity if we need to do so and to fund working capital for anticipated growth. If we do not generate sufficient cash flow from operations or otherwise have the capital resources to meet our future capital needs, we may need additional financing to implement our business strategy.

 

If we raise additional funds through the issuance of our common stock or convertible securities, the ownership interests of our stockholders could be significantly diluted. These newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. Additional financing may not, however, be available on terms favorable to us, or at all, if and when needed, and our ability to fund our operations, take advantage of unanticipated opportunities, develop or enhance our infrastructure or respond to competitive pressures could be significantly limited. If we cannot raise required capital when needed, including under our Short Form Prospectus filed with the Canadian Securities Exchange and the U.S. SEC in October 2016, we may be unable to continue technology and product development, meet the demands of existing and prospective customers, adversely affecting our sales and market opportunities and consequently our business, financial condition and results of operations.

 

Our business could be negatively impacted as a result of shareholder activism.

 

In recent years, shareholder activists have become involved in numerous public companies. Shareholder activists frequently propose to involve themselves in the governance, strategic direction, and operations of the company. We may in the future become subject to such shareholder activity and demands. Such demands may disrupt our business and divert the attention of our management and employees, and any perceived uncertainties as to our future direction resulting from such a situation could result in the loss of potential business opportunities, be exploited by our competitors, cause concern to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners, all of which could adversely affect our business. In addition, actions of activist shareholders may cause significant fluctuations in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying fundamentals and prospects of our business. 

 

If we fail to protect, or incur significant costs in defending, our intellectual property and other proprietary rights, our business and results of operations could be materially harmed.

 

Our success depends on our ability to protect our intellectual property and other proprietary rights. We rely on a combination of patent, trademark, copyright, trade secret and unfair competition laws, as well as license agreements and other contractual provisions, to establish and protect our intellectual property and other proprietary rights. We have applied for patent registrations in the U.S. and in foreign countries, some of which have been issued. We cannot guarantee that our pending applications will be approved by the applicable governmental authorities. Moreover, our existing and future patents and trademarks may not be sufficiently broad to protect our proprietary rights or may be held invalid or unenforceable in court. A failure to obtain patents or trademark registrations or a successful challenge to our registrations in the U.S. or foreign countries may limit our ability to protect the intellectual property rights that these applications and registrations intended to cover.

 

  27  

 

Policing unauthorized use of our technology is difficult and we cannot be certain that the steps we have taken will prevent the misappropriation, unauthorized use or other infringement of our intellectual property rights. Further, we may not be able to effectively protect our intellectual property rights from misappropriation or other infringement in foreign countries where we have not applied for patent protections, and where effective patent, trademark, trade secret and other intellectual property laws may be unavailable or may not protect our proprietary rights as fully as Canadian or U.S. law. We may seek to secure comparable intellectual property protections in other countries. However, the level of protection afforded by patent and other laws in other countries may not be comparable to that afforded in Canada and the U.S.

 

We also attempt to protect our intellectual property, including our trade secrets and know-how, through the use of trade secret and other intellectual property laws, and contractual provisions. We enter into confidentiality and invention assignment agreements with our employees and independent consultants. We also use non-disclosure agreements with other third parties who may have access to our proprietary technologies and information. Such measures, however, provide only limited protection, and there can be no assurance that our confidentiality and non-disclosure agreements will not be breached, especially after our employees end their employment, and that our trade secrets will not otherwise become known by competitors or that we will have adequate remedies in the event of unauthorized use or disclosure of proprietary information. Unauthorized third parties may try to copy or reverse engineer our products or portions of our products, otherwise obtain and use our intellectual property, or may independently develop similar or equivalent trade secrets or know-how. If we fail to protect our intellectual property and other proprietary rights, or if such intellectual property and proprietary rights are infringed or misappropriated, our business, results of operations or financial condition could be materially harmed.

 

In the future, we may need to take legal actions to prevent third parties from infringing upon or misappropriating our intellectual property or from otherwise gaining access to our technology. Protecting and enforcing our intellectual property rights and determining their validity and scope could result in significant litigation costs and require significant time and attention from our technical and management personnel, which could significantly harm our business. We may not prevail in such proceedings, and an adverse outcome may adversely impact our competitive advantage or otherwise harm our financial condition and our business.   

 

We may be involved in intellectual property disputes in the future, which could divert management’s attention, cause us to incur significant costs and prevent us from selling or using the challenged technology.

 

Participants in the markets in which we sell our products have experienced frequent litigation regarding patent and other intellectual property rights. There can be no assurance that third parties will not assert infringement claims against us, and we cannot be certain that our products would not be found infringing on the intellectual property rights of others. Regardless of their merit, responding to such claims can be time consuming, divert management’s attention and resources and may cause us to incur significant expenses. Intellectual property claims against us could result in a requirement to license technology from others, discontinue manufacturing or selling the infringing products, or pay substantial monetary damages, each of could result in a substantial reduction in our revenue and could result in losses over an extended period of time.

 

If we fail to obtain the right to use the intellectual property rights of others that are necessary to operate our business, and to protect their intellectual property, our business and results of operations will be adversely affected.

 

From time to time, we may choose to or be required to license technology or intellectual property from third parties in connection with the development of our products. We cannot assure you that third party licenses will be available to us on commercially reasonable terms, if at all. Generally, a license, if granted, would include payments of up-front fees, ongoing royalties or both. These payments or other terms could have a significant adverse impact on our results of operations. Our inability to obtain a necessary third-party license required for our product offerings or to develop new products and product enhancements could require us to substitute technology of lower quality or performance standards, or of greater cost, either of which could adversely affect our business. If we are not able to obtain licenses from third parties, if necessary, then we may also be subject to litigation to defend against infringement claims from these third parties. Our competitors may be able to obtain licenses or cross-license their technology on better terms than we can, which could put us at a competitive disadvantage.

 

  28  

 

If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be adversely affected.

 

Preparing our consolidated financial statements involves a number of complex manual and automated processes, which are dependent upon individual data input or review and require significant management judgment. One or more of these elements may result in errors that may not be detected and could result in a material misstatement of our consolidated financial statements. The Sarbanes-Oxley Act in the U.S. requires, among other things, that as a publicly traded company we disclose whether our internal control over financial reporting and disclosure controls and procedures are effective. As long as we qualify as an “emerging growth company” under the JOBS Act, which may be up to five years following the filing of our Form 20F Registration Statement, we will not have to provide an auditor’s attestation report on our internal controls. During the course of any evaluation, documentation or attestation, we or our independent registered public accounting firm may identify weaknesses and deficiencies that we may not otherwise identify in a timely manner or at all as a result of the deferred implementation of this additional level of review.

 

We have implemented internal controls that we believe provide reasonable assurance that we will be able to avoid accounting errors or material weaknesses in future periods. However, our internal controls cannot guarantee that no accounting errors exist or that all accounting errors, no matter how immaterial, will be detected because a control system, no matter how well designed and operated, can provide only reasonable, but not absolute assurance that the control system’s objectives will be met. If we are unable to implement and maintain effective internal control over financial reporting, our ability to accurately and timely report our financial results could be adversely impacted. This could result in late filings of our annual and quarterly reports under the Canadian Securities Act and the Securities Exchange Act of 1934, or the Exchange Act, restatements of our consolidated financial statements, a decline in our stock price, suspension or delisting of our common stock by the TSX Venture Exchange, or other material adverse effects on our business, reputation, results of operations or financial condition. 

 

Our ability to use our net operating losses and certain other tax attributes may be limited.

 

As of December 31, 2017, we had accumulated net operating losses (“NOLs”), of approximately $124 million. In the interim period through June 30, 2018 we have incurred additional losses for accounting purposes from operations of $7.9 million. Varying jurisdictional tax codes have restrictions on the use of NOLs, if a corporation undergoes an “ownership change,” the Company’s ability to use its pre-change NOLs, research and development (“R&D”) credits and other pre-change tax attributes to offset its post-change income may be limited. An ownership change is generally defined as a greater than 50% change in equity ownership. Based upon an analysis of our equity ownership, we do not believe that we have experienced such ownership changes and therefore our annual utilization of our NOLs is not limited. However, should we experience additional ownership changes, our NOL carry forwards may be limited.

 

We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.

 

We are subject to export and import control laws, trade regulations and other trade requirements that limit which raw materials and technology we can import or export and which products we sell and where and to whom we sell our products. Specifically, the Bureau of Industry and Security of the U.S. Department of Commerce is responsible for regulating the export of most commercial items that are so called dual-use goods that may have both commercial and military applications. A limited number of our products are exported by license under certain classifications. Export Control Classification requirements are dependent upon an item’s technical characteristics, the destination, the end-use, and the end-user, and other activities of the end-user. Should the regulations applicable to our products change, or the restrictions applicable to countries to which we ship our products change, then the export of our products to such countries could be restricted. As a result, our ability to export or sell our products to certain countries could be restricted, which could adversely affect our business, financial condition and results of operations. Changes in our products or any change in export or import regulations or related legislation, shift in approach to the enforcement or scope of existing regulations, or change in the countries, persons or technologies targeted by such regulations, could result in delayed or decreased sales of our products to existing or potential customers. In such event, our business and results of operations could be adversely affected.

 

  29  

 

Our manufacturing operations are subject to environmental regulation that could limit our growth or impose substantial costs, adversely affecting our financial condition and results of operations.

 

Our properties, operations and products are subject to the environmental laws and regulations of the jurisdictions in which we operate and sell products. These laws and regulations govern, among other things, air emissions, wastewater discharges, the management and disposal of hazardous materials, the contamination of soil and groundwater, employee health and safety and the content, performance, packaging and disposal of products. Our failure to comply with current and future environmental laws and regulations, or the identification of contamination for which we are liable, could subject us to substantial costs, including fines, cleanup costs, third-party property damages or personal injury claims, and make significant investments to upgrade our facilities or curtail our operations. Identification of presently unidentified environmental conditions, more vigorous enforcement by a governmental authority, enactment of more stringent legal requirements or other unanticipated events could give rise to adverse publicity, restrict our operations, affect the design or marketability of our products or otherwise cause us to incur material environmental costs, adversely affecting our financial condition and results of operations.  

 

We are exposed to risks and increased expenses and business risk as a result of Restriction on Hazardous Substances, or RoHS directives.

 

Following the lead of the European Union, or EU, various governmental agencies have either already put into place or are planning to introduce regulations that regulate the permissible levels of hazardous substances in products sold in various regions of the world. For example, the RoHS directive for EU took effect on July 1, 2006. The labeling provisions of similar legislation in China went into effect on March 1, 2007. Consequently, many suppliers of products sold into the EU have required their suppliers to be compliant with the new directive. We anticipate that our customers may adopt this approach and will require our full compliance, which will require a significant amount of resources and effort in planning and executing our RoHS program, it is possible that some of our products might be incompatible with such regulations. In such events, we could experience the following consequences: loss of revenue, damages reputation, diversion of resources, monetary penalties, and legal action.  

 

Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences.

 

We are subject to the U.S. Foreign Corrupt Practices Act, which generally prohibits companies operating in the U.S. from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. In addition, we are required to maintain records that accurately and fairly represent our transactions and have an adequate system of internal accounting controls. Non-U.S companies, including some that may compete with us, may not be subject to these prohibitions, and therefore may have a competitive advantage over us. If we are not successful in implementing and maintaining adequate preventative measures, we may be responsible for acts of our employees or other agents engaging in such conduct. We could suffer severe penalties and other consequences that may have a material adverse effect on our financial condition and results of operations. 

 

  30  

 

Natural disasters or other catastrophic events could harm our operations.

 

Our operations in the U.S., Canada and Singapore could be subject to significant risk of natural disasters, including earthquakes, hurricanes, typhoons, flooding and tornadoes, as well as other catastrophic events, such as epidemics, terrorist attacks or wars. For example, our wafer fabrication facility in Singapore is in an area that is susceptible to hurricanes. Any disruption in our manufacturing facilities arising from these and other natural disasters or other catastrophic events could cause significant delays in the production or shipment of our products until we are able to arrange for third parties to manufacture our products. We may not be able to obtain alternate capacity on favorable terms or at all. Our property insurance coverage with respect to natural disaster is limited and is subject to deductible and coverage limits. Such coverage may not be adequate or continue to be available at commercially reasonable rates and terms. The occurrence of any of these circumstances may adversely affect our financial condition and results of operation. 

 

The Company may experience these factors in the future and these factors may have a material adverse effect on the Company’s business, operating results and financial condition.

 

Please refer to the Company's Annual Information Forms filed on SEDAR for a detailed discussion of Risks and Uncertainties most recently filed on May 9, 2018.

 

Additional Information

 

Additional information relating to the Company is available on SEDAR at www.sedar.com including the information contained in the Company's Annual Information Form filed on SEDAR on May 9, 2018.

 

 

 

 

 

 

 

 

 

  31  

 

 

 

 

 

 

 

POET TECHNOLOGIES INC.

Suite 1107, 120 Eglinton Ave. E 780 Montague Expy #107

Toronto, Ontario M4P 1E2 San Jose, CA 95131 USA

Tel: 416-368-9411 - Fax: 416-322-5075

http://www.poet-technologies.com

 

32


 

Exhibit 99.3

 

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

 

I, Suresh Venkatesan, Chief Executive Officer of POET Technologies Inc. , certify the following:

 

1. Review: I have reviewed the interim financial report and interim MD&A, (together, the “interim filings”) of POET Technologies Inc. (the “issuer”) for the period ended June 30, 2018.

 

2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.

 

3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

 

(a) designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

 

(i) material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii) information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b) designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) (COSO Framework) as issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission.

 

5.2 ICFR: Not applicable

 

5.3 Limitation on scope of design: Not applicable

 

6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: August 15, 2018

 

 

  By: /s/ Suresh Venkatesan
  Suresh Venkatesan
  Chief Executive Officer

 

Exhibit 99.4

 

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

 

I, Thomas Mika, Chief Financial Officer of POET Technologies Inc. , certify the following:

 

1. Review: I have reviewed the interim financial report and interim MD&A, (together, the “interim filings”) of POET Technologies Inc. (the “issuer”) for the period ended June 30, 2018.

 

2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.

 

3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

 

4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

 

(a) designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

 

(i) material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

(ii) information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

(b) designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) (COSO Framework) as issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission.

 

5.2 ICFR: Not applicable

 

5.3 Limitation on scope of design: Not applicable

 

6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: August 15, 2018

 

 

  By: /s/ Thomas Mika
  Thomas Mika
  Chief Financial Officer